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ABSTRACT
Postpartum depression (PPD) is depression that occurs in women following childbirth occurring
during the postpartum period and affects 1 in 7 women (The United States Preventive Services
Task Force, 2019). The American Academy of Pediatrics [AAP] (2019), recommends that
pediatric healthcare providers utilize their position to screen for PPD. The purpose of this
evidence-based practice (EBP) project was to implement a PPD screening intervention within a
pediatric healthcare setting using the Edinburgh Postnatal Depression Scale (EPDS). The
Academic Center for Evidence-Based (ACE) Practice Star Model guided this EBP project with
evidence-based interventions developed after a comprehensive literature search.
Implementation of the EBP project occurred in a pediatric office in northeast, Indiana in which
eligible mothers were screened at their child’s 1, 2, 4, and 6-month well-child visits. A total of 30
participants were screened for risk for PPD at their child’s initial well-child visit and then 12
weeks later with a follow-up phone call. Interventions to increase awareness of PPD were
delivered to participants based on their EPDS scores. Participants scoring greater than 10 were
identified as highest risk for PPD and were provided with community resources, PPD
educational information, and a referral to their obstetrician/gynecologist (OB/GYN), or primary
care provider (PCP). Those who scored less than 10 received community resources and PPD
educational information to review at their convenience. A 12-week follow-up phone call was
conducted for all participants post-intervention. A paired-samples t-test indicated a significant
decrease from pre-intervention EPDS total score was found t(29) = 6.625, p < .001. The mean
of the pre-intervention EPDS score was 4.83 (4.65) and the mean of the pre-intervention
OB/GYN or PCP follow-up was 2.67 (0.76). A significant decrease from the pre-intervention
EPDS score to follow-up was found t(29) = 2.259, p < 0.05. A one-way between subjects’
ANOVA was conducted to compare the effect of past medical history on EPDS total scores.
There was a significant effect of past medical history on EPDS total scores at the p < .05 level
for the three conditions F(4, 25) = 3.121, p = 0.033.
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CHAPTER 1
INTRODUCTION
Background

According to the United States Preventive Services Task Force [USPSTF] (2019),
postpartum depression (PPD) is depression that occurs in women after childbirth, it affects as
many as 1 in 7 women and is the most common within the postpartum period. Symptoms for
postpartum depression include “loss of interest and energy, expressed mood, fluctuations in
sleep or eating patterns, reduced ability to think or concentrate, feelings of worthlessness, and
recurrent suicidal ideation” (USPSTF, 2019, p. 1). These symptoms can have negative short
and long-term effects not only for mothers but also for their children (USPSTF, 2019, p.1).
Women who suffer from PPD exhibit significantly higher levels of negative and lower levels of
positive behavior toward their child (i.e. praising or playing with their child), increase
breastfeeding cessation, receive fewer preventive health services (i.e. vaccinations), and
influence the child’s cognitive and emotional development with an increased risk for psychiatric
disorders in their children (USPSTF, 2019).
The Centers for Disease Control and Prevention (CDC) identify potential risk factors that
are associated with the development of postpartum depression. These risk factors include
experiences that may affect mothers’ moods, for instance, “stressful live events, low social
support, family history of depression, being a teen mom, mom of multiples, history of
depression, preterm delivery, pregnancy complications, birth complications and having a baby
that is hospitalized” (CDC, 2017). Although there are many risk factors that can increase the
chances of developing postpartum depression, this condition can occur within a healthy
pregnancy, or in women who experienced a normal birth and delivery of a healthy baby. While
the CDC identifies social experiences that may alter women’s moods increasing their chances
of having postpartum depression, the USPSTF identifies other contributing risk factors. Risk
factors such as “low socioeconomic status, lack of support, genetic factors, history of physical or
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sexual abuse, unplanned pregnancy, lack of financial support and gestational diabetes”
(USPSTF, 2019, p.1). These risk factors help providers have a better understanding of their
patients when screening for postpartum depression.
Postpartum depression screening is done using different tools with the most frequently
reported being the Edinburgh Postnatal Depression Screening (EPDS), Personal Health
Questionnaire 2 (PHQ-2) or Personal Health Questionnaire 9 (PHQ-9). These screening tools
help determine how mothers have been coping with their feelings and provide healthcare
providers with the information they need to properly assess their mental state.
Data from the Literature Supporting Need for the Project
According to the American Academy of Pediatrics [AAP] (2019), 10% of women suffer
from depression during the postpartum period, but less than half of those cases are recognized.
Therefore, a screening process for depression is needed to provide opportunities to improve
outcomes for both mother and child. AAP (2019) recommends that pediatric health care
providers are in a great position to screen mothers for postpartum depression due to the
frequent visits that occur in the first year of life for their child. Since these providers are wellpositioned to screen mothers for postpartum depression, AAP recommends integrating a
screening process at the 1, 2, 4, and 6 months well-child visits. The USPSTF and Centers for
Medicare and Medicaid Services (CMS) both support PPD screening and supports the
recognition of screening as an evidence-based recommendation, whereas providers are able to
close the gap in the rates of PPD screening. As of 2017, the AAP, USPSTF, and CMS
recognize that PPD screenings measure the risk of the infant’s environment, therefore billing for
this type of screening conducted during office visits is appropriate. The Current Procedural
Terminology (CPT) code for post-partum depression screening during well child encounters is
96161 “Administration of caregiver-focused health risk assessment instrument for the benefit of
the patient, with scoring and documentation, per standardized instrument” (AAP, 2016, p.1).
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Therefore, screening in a pediatric office is appropriate and the capability for billing and coding
is indicated.
Data from the Clinical Agency Supporting Need for the Project
The proposed pediatric clinical site in Fort Wayne, IN currently does not screen for
maternal depression in their office. Furthermore, providers are not consistent in their screening
methods, documentation of the screening, and subsequently the education and/or referral
process for those scoring at risk for PPD at this clinical setting. This site is a privately-owned
medical clinic in which EBP is frequently integrated into practice by the primary medical
provider. The primary medical provider was interested in implementing a maternal depression
screening within his office as recommended by the AAP. Most pediatricians in the city of Fort
Wayne, IN do not screen for postpartum depression (personal communication, medical director,
April-June 2019). Many providers that do screen for postpartum depression have been
practicing for years and have had someone implement the screening process within their
practice for them or are personally interested in the screening process (personal
communication, medical director, May 2019). The provider at the proposed project site was
excited for the screenings to be integrated within his practice and was prepared to help in any
way possible (personal communication, medical director, May 2019). Relationships between
pediatrician providers and obstetricians (OB) is based on location. Some pediatrician providers
are linked to the OBs offices and share electronic medical records. This proposed project site
was not linked to OBs offices and does not share a similar electronic medical record as OB
offices or hospitals.
The population presenting to this clinic for care is diverse including a variety of ethnic
backgrounds including Caucasians, Hispanics, Asians and African Americans. There was
Spanish speaking office staff available to assist with patients and their families that do not speak
or interpret English well. The provider believes in holistic treatment and refers to natural
products as much as possible (personal communication, medical director, May 2019). The
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medical provider at this clinic approaches illnesses will natural safe supplements when
necessary. The culture of the office is health first, promoting healthy eating and living (Jefferson
Pediatrics PC, 2014). There is one nurse practitioner (NP) and two physician assistants (PAs)
that conduct new well-child visits as well as the primary provider. Each provider adheres to the
office culture of being natural and promoting holistic treatment (Jefferson Pediatrics PC, 2014).
Purpose of the Evidence-Based Practice Project
Evidence has demonstrated that maternal depression is prevalent among postpartum
women and is not being recognized. According to the United Health Foundation and data
retrieved from the CDC, there was no data reported for the state of Indiana related to the
incidence of postpartum office visits for women following delivery (2019). Although there was no
data reported for postpartum visits, the 2018 visits for the well-baby check was 93.1% (United
Health Foundation, 2019). The pediatric setting has been identified as an avenue for captivating
the maternal population during the postpartum period, who may otherwise not follow up with a
provider, thus closing the gap in PPD screening. The purpose of this EBP project was to
implement a postpartum depression screening intervention within a pediatric setting using a
synthesis of current evidence by utilizing the EPDS screening tool to identify depression in
postpartum women within the first year of their infant’s life. By doing so this minimizes the future
risk of undiagnosed of depression within postpartum women and negative health consequences
for their children. Hence, the compelling clinical question that initiated this EBP project was:
What is the effect of screening women for postpartum depression within a pediatric setting? The
aims of the project were to increase awareness and recognition of PPD in postpartum women
up to one year after delivery, which ultimately reduces the rates of undiagnosed women.
PICOT Question
Specifically, this project will address the following PICOT question: “In postpartum
women (P), how does the implementation of a screening and referral protocol (I) for postpartum
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depression in a pediatric setting affect mental well-being (EPDS scores) (O), as, compared to
the current practice (C) over a twelve-week period (T)?”.
Significance of the EBP Project
Postpartum depression is common, with potentially life-threatening effects on mother
and babies during the first year of life. This EBP project seems well-timed since the
recommendation of screening for PPD in a pediatric setting was reported in 2010 by the AAP.
Being that maternal depression affects the whole family, it is essential that the gap is closed,
screening rates increase, and pediatricians recognize the signs of postpartum depression given
the frequent contact with parents of infants (AAP, 2019).
“PND (perinatal depression) peaks in women 18 to 44 years of age. In general, as many
as 12% of all women who are pregnant or in the postpartum period experience depression
in a given year, and 11% to 18% of women report postpartum depression symptoms. The
prevalence in women with low income is estimated to be double at 25%”. “Minor
depression peaks at 2 to 3 months postpartum, and the peak for major depression is at 6
weeks postpartum” while there is also another peak for depression at the 6-month period
postpartum (Rafferty et al., 2019, p. 2).
These peaks of postpartum depression occur after OB visits, therefore the need for continued
screening is indicated in a different setting such as a pediatric office.
This EBP project sought to provide additional profundity to the current evidence
regarding maternal screening for PPD within a pediatric setting. The results may provide
observable information for providers, patients, and office staff. Pediatrician offices may use the
findings to revise policies, protocols, and assessments across different pediatrician offices and
health care settings. The interventions were implemented to increase awareness of postpartum
depression and close the gap of missed opportunities to address mothers at risk for postpartum
depression. Protocols were established to aid providers to navigate and intervene based on
screening results. This ensures consistency of screening across providers at the proposed
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clinic. This protocol also included educational information including a list of resources and
referral recommendations for mothers (see Appendix G). Results may be used by other
advanced practice registered nurses (APRNs) to facilitate maternal care in a pediatric setting
aiming to increase patient outcomes which ultimately impact family dynamics and family health
as a whole.
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CHAPTER 2

EVIDENCE-BASED PRACTICE MODEL AND REVIEW OF LITERATURE
Evidence-based Practice Model
Overview of EBP Model
The Academic Center for Evidence-Based Practice (ACE) Star Model was used to aid in
guiding the development of this EBP project. The ACE Star Model was developed at the
University of Texas Health Science Center in San Antonio. There are many challenges that
present when transitioning research into practice, but the ACE Star Model has developed a
pathway to overcoming these obstacles. “The ACE Star Model explains how to overcome the
challenges of (1) the volume of research evidence, (2) the misfit between form and use of
knowledge, and (3) integration of expertise and patient preference into best practice” (Melnyk &
Fineout-Overholt, 2015, p.305). This model helps aid in the understanding of nature, cycles, and
knowledge that are used in the different aspects of evidence-based practice. According to
Stevens (2012), “the Star Model places nursing’s previous scientific work within the context of
EBP, serves as an organizer for examining and applying EBP, and mainstreams nursing into the
formal network of EBP” (p. 1).
The ACE Star Model explains how various forms of knowledge are essential when
transforming research into practice. For example, the inclusion of systematic reviews and
clinical practice guidelines are forms of knowledge that can be used as supporting evidence to
guide EBP initiatives. These various forms of knowledge move through several cycles which
include a combination of knowledge and integration into practice. The model provides a
systematic framework for integrating research into practice through five stages of knowledge
transformation. These stages are (a) discovery research, (b) evidence summary, (c) translation
to guidelines, (d) practice integration, and (e) process, outcome evaluation (Melnyk & FineoutOverholt, 2015). Stevens (2012) states that knowledge transformation is “the conversion of
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research findings from primary research results, through a series of stages and forms to impact
on health outcomes by way of evidence-based care” (p. 1).
Application of EBP Model to DNP Project
Star point one (stage one) of the five-stage process is discovery research. Also known
as the knowledge-generating stage. During this stage, it is essential to discover what the
research indicates about the clinical burning question and how EBP projects are developed. For
this EBP project, this stage included research that supported the lack of implementation of
proper assessing/screening of postpartum depression and how it affects postpartum mothers.
The project coordinator initially reviewed single studies that evaluated the effects of screening
for postpartum depression. This led to the discovery that screening postpartum depression
within a pediatric setting has not yet been widely implemented across the nation and is
recommended as a best practice strategy. Although screening for postpartum depression in a
pediatric setting is supported in the literature, not all pediatric offices are implementing this
screening process. Thus, the decision to move forward in evaluating further studies regarding
the implementation of screening postpartum women for postpartum depression within a
pediatrician clinic emerged. Once the review of further supportive studies occurred, progression
into the second stage of the ACE Star Model was deemed appropriate.
Star point two (stage two) of the five-stage process is an evidence summary. This is also
considered a knowledge-generating stage, where “evidence summaries produce new
knowledge by combining findings from all studies to identify bias and limit chance effects in the
conclusions” (Stevens, 2012, p. 1). For this EBP project, the synthesis of literature essentially
served as the evidence summary. The use of the critical appraisal of the evidence was used to
determine what is high quality for use to guide the interventions. Common themes throughout
the literature such as, type of tool, referral process and incorporation within the practice were
described. This high-quality evidence guided this EBP project by providing the best
interventions and recommendations.
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The translation is the star point three (stage three) of the five- stage process. This stage
actually encompasses two stages, translating evidence into a practice recommendation and
integration into practice. Essentially, this can be defined as taking the evidence and combining it
with clinical expertise to implement it into practice. As for this EBP project, there are clinical
guidelines as well as single research studies being used to support the recommendation. The
clinical guidelines on implementing postpartum screening within a pediatric setting have been
developed by the AAP and Association of Women’s Health, Obstetric and Neonatal Nurses
(AWHONN) which were used to guide this EBP project. Stevens (2012) states “summarized
research evidence is interpreted and combined with other sources of knowledge and then
contextualized to a specific client population and setting” (p. 1). For this EBP project, the best
practice model indicates the targeted population should be postpartum women attending wellchild visits within a pediatric setting.
The fourth point in the five-stage process is, practice integration, which is considered
“the most familiar stage in healthcare because of society’s long-standing expectation that
healthcare is based on the most current knowledge, thus, requiring the implementation of
innovations” (Stevens, 2012, p. 1). This current knowledge once implemented into practice is
considered best practice. Relating to this EBP project, the project coordinator facilitated this
stage by ensuring proper education supporting the need for the project was provided to office
personnel. For success during this stage, it was essential that the staff and providers bought-in
and understood the importance of screening and its impact on the child’s health. Furthermore,
project recruitment and participation included clear and purposefully detailed information to
eligible postpartum women highlighting the importance of screening for postpartum depression.
Interventions were carefully planned so as not to disturb the normal workflow of the office or
staff within the pediatric project site.
The last stage (stage five) of the ACE Star Model is evaluation, which includes process
and outcomes. This stage “is an inclusive view of the impact that the EBP has on patient health
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outcomes, satisfaction, efficacy and efficiency of care, and health policy” (Melnyk & FineoutOverholt, 2015, p. 306). According to Stevens (2012), “the final outcome is evidence-based
quality improvement of health care” (p.1). As knowledge is transformed through each of the five
stages of the ACE Star Model the final outcome of this EBP project was focused on the health
of postpartum women and their infants by increasing proper screening for postpartum
depression. The purpose of this screening strategy within a pediatric setting was to identify PPD
in women who may have been missed if not screened appropriately during their obstetric visits
or neglected to follow up with a provider during their postpartum period.
Strengths and Limitations of EBP Model for DNP Project
The strengths of the ACE Star Model for this EBP project included its ease of use and
capability to transition through the five stages. This model aided in the organization and
interpretation of relevant information to be applicable within the healthcare system. A strength
the model had was increasing the understanding of the science of EBP. Understanding the
science of EBP and how clinical practice guidelines can initiate the application of research into
practice was a key component of this EBP project, which was emphasized in one of the stages
of the ACE Star Model. The uniqueness of the ACE Star Model’s aim was to create new
knowledge, while this EBP project aim was to create new knowledge based on the outcomes of
postpartum depression screening within a pediatric setting.
There were some limitations of this model, including that the stages of the model were
intended to be progressed through in a chronological sequence. The model does not appear to
have a linear effect, rather a circular model, which indicates that the project leader would start
over or repeat the cycle. The model does not appear to have an ending. When using it for
implementing new knowledge into a healthcare facility, having an understanding of an end is
prudent.
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Literature Search

Sources Examined for Relevant Evidence
A search was completed for relevant evidence to identify the benefits of screening for
PPD within a pediatric setting. The databases that were examined include the Cumulative Index
to Nursing and Allied Health Literature (CINAHL), Joanna Briggs Institute (JBI), Cochrane
Library, ProQuest Nursing and Allied Health Source, PsycINFO, and Medline. Support from the
Valparaiso University health sciences librarian was utilized to narrow and focus key terms based
on databases searched. The MeSH (medical subject heading) system and Boolean system
were used in order to keep consistency throughout the different databases. Initial key terms
used within the literature search prior to coordinating with the librarian included postpartum
depression, postnatal depression, PPD, pediatrician, pediatrics, pediatrician offices, well child
visits (WCV). After collaborating with the librarian, the use of MeSH terms and Boolean
operators were utilized for a more advanced literature search. The best combination of phrases
and key terms included “postpartum depression” OR “postnatal depression” AND pediatric* OR
“pediatrician office” OR “well-child visit*”. Abstracts were reviewed that contained these key
terms or phrases.
Abstracts were considered for inclusion as supporting evidence for this project if they
were (a) written in English, (b) peer-reviewed, and (c) published within the last five years
(between 2014 to 2019). Exclusion criteria for abstracts included (a) those abstracts that were
conducted outside of the United States, (b) published in different languages (non-English), (c)
the interventions were not implemented in a pediatric setting,(d) the abstract provided
background information regarding postpartum depression, knowledge, or attitudes toward and
definitions, and (e) articles that included a prenatal depression screening. These abstracts were
eliminated due to the lack of support and applicability to the population of interest.
After a complete review of the abstracts and elimination of duplicate citations from the
searched databases, a total of 14 articles were considered appropriate for the development of
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the EBP project (see Table 2.1). After the systematic search was completed within each
database, retrieval of the supportive articles of evidence was completed. CINAHL yielded 47
results with nine articles deemed relevant to the EBP project. Of these nine articles, there was a
policy statement from the AAP as well as a position JBI database search included simple search
phrases such as “postpartum depression” OR “postnatal depression” and resulted in 38 articles
while only one was relevant to the EBP project. The Cochrane Library database search utilizing
the simple search terms postpartum depression” OR “postnatal depression” yielded 34 results
with none being relevant to the EBP project. The search within Medline via EBSCO utilized
MeSH terms combined with Boolean operators (MM’ Postpartum Depression) AND pediatric*
OR “pediatrician office” OR “well-child visit*” yielded 103 results and after elimination of
duplicate citations, resulted in one relevant article. Replication of the search terms used within
Medline yielded two articles from the ProQuest database both of which were relevant and met
inclusion criteria. The same search, utilizing the MeSH terms and Boolean operators within
PsycINFO yielded 47 articles and after elimination of duplications, one article was included for
the EBP project. Five chased citations lead to one pilot study within the Journal of Clinical
Pediatrics that was deemed relevant to the EBP project.
Levels of Evidence
After the selection of the fourteen articles, it was essential to appropriately evaluate each
piece of evidence to ensure these articles were relevant and of good quality for the EBP project.
The Johns Hopkins Nursing Evidence-Based Practice (JHNEBP) Research Evidence Appraisal
Tool was utilized to evaluate each piece of evidence retrieved for use in the development of this
EBP project. Within this tool, each piece of evidence was identified by the type of study design
and appraised using a structured set of questions that assist with rating the research pieces
evidence according to level (I-V) and quality (A-C). Level I includes experimental study,
randomized controlled trials (RCTs), explanatory mixed-method design that includes only a level
I quantitative study and systematic review of RCTs with or without meta-analysis. Within this
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EBP project, a perspective cohort study was utilized as level I. Level II includes quasiexperimental study, explanatory mixed-method design that includes a level II quantitative study,
systematic review of a combination of RCTs and quasi-experimental studies, or quasiexperimental studies only, with or without meta-analysis. This EBP project yielded three level II
articles which included quasi-experimental, pilot study and systematic review. Level III includes
nonexperimental study, systematic review of a combination of RCTs, quasi-experimental and
nonexperimental studies, or nonexperimental studies only, with or without meta-analysis,
exploratory, convergent, or multiphasic mixed methods studies, explanatory mixed method
design that includes only a level III quantitative study, qualitative study, and meta-synthesis. An
appraisal of evidence was utilized as level III within this EBP project. Level IV evidence levels
include an opinion of respected authorities and/or nationally recognized expert committees or
consensus panels based on scientific evidence, including clinical practice guidelines, consensus
panels/position statements. Two recommendation/position statements were used as level IV
articles in the development of this EBP project. Level V evidence includes evidence-based on
experiential and nonresearched evidence, including integrative reviews, literature reviews,
quality improvement, program or financial evaluation, case reports and opinion of nationally
recognized experts based on experiential evidence. The level V articles utilized for this EBP
project included three literature reviews, an evidence summary and three quality improvement
articles.
Appraisal of Relevant Evidence
The JHNEBP Research Evidence Appraisal Tool is designed to lay the foundation “for
understanding the importance of implementing EBP in a transformed healthcare environment,
emphasizing the necessity for continuous quality improvement and cost-effectiveness” (Dearholt
& Dang, 2017, p.xxi). The appraisal tool includes a set of questions for each type of evidence
retrieved that determines the type, quality, and level of each piece of evidence that is appraised.

YOU’RE NOT FORGOTTEN

14

Within this tool, there are evidence rating levels ranging from Level I (highest) to Level V
(lowest) that are assigned to the pieces of the evidence appraised. Within each level, there is
also a rating for the individual pieces of evidence categorized as A (high quality), B (good
quality) or C (low quality/major flaws). The final articles chosen for the EBP project have a
variety of leveling and quality ratings which helps support the PICOT question and purpose of
this project. Having lower-rated articles such as can indicate that there was a small sample size
or that the study was considered a quality improvement project rather than research. Although
there were some low-quality articles included within the final supportive evidence guiding this
EBP project, this does not imply that they were not beneficial to project implementation and
achieving desired outcomes. These articles provided a great foundation for the project purpose
and diversify the evidence provided. The final literature appraisal included fourteen pieces of
evidence: four-level I (1-prospect cohort, 1-evidence summary & 2- systematic reviews), twolevel II (quasi-experimental study & pilot study), two-level IV (2- clinical guidelines) and six-level
V (3- literature reviews & 3- quality improvements) (See Table 2.2). The level of evidence was
determined using the JHNEBP Research Evidence Appraisal Tool and organized in an evidence
summary table in Appendix A.
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Table 2.1
Evidence Search Table

Results

Duplicates
Articles

Abstracts
Reviewed

Articles
Appraised

CINAHL

47

0

15

9

JBI

38

0

1

1

Cochrane

34

5

1

0

MEDLINE

103

15

1

1

ProQuest

2

0

2

1

PsycINFO

155

12

2

1

5

0

1

1

Database

Chasing
Total:

14

Table 2.2
Levels of Evidence and Quality Grade Table
Levels of Evidence

Number of Articles

Level I

1

Level II

3

Level III

1

Level IV

2

Level V

7

Quality Grade

Number of Articles

A (high quality)

7

B (good quality)

7

C (poor quality)

0
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Level I evidence.
Emerson, Matthews, and Struwe (2018) conducted a prospective cohort study to
determine the prevalence of PPD in new mothers during screenings at the 2-, 4- and 6-month
well-child visit (WCV) in an urban outpatient pediatric, examine feasibility factors relative to
extending the current standard of care for PPD screenings; and examine visit documentation for
at-risk mothers. A study was conducted over a 6-month period to gather information regarding
screenings for new mothers at their 6-month well-child visit. This article was well written and
organized (grade A). The quality of the prospective cohort study was very well explained and
detailed. Inclusion criteria included postpartum women (not pregnant), able to read and
understand English, 19 years or older, and attending the 6-month WCV. There was a clear
statement of purpose and methods for evaluation were clearly stated. Data collection methods
were stated clearly, and participants were given consent to participate. The study’s strengths
and limitations were indicated in the article. The study resulted in forty-three women
participants, while prevalence rated among participants was 10%, 12.5% and 14% for 2-month,
4-month, and 6-month visits. Two of the six mothers that were identified to have a positive
screening did not have a positive screening at the 2- and 4-month visit, while the remaining four
had a positive screening at the 4-month visit. Concluded that the prevalence of postpartum
depression among the participants is consistent with previous rates anticipated. The prevalence
rate of positive EPDS for the 6-month WCV prevalence rates at 14%. The prevalence rate for
the 2-month WCV was 10% and 12.5% for 4-month WCV. There were 47% of the visits that
contained documentation of suicide, while treatment options and PPD education was
documented at 87% of the visits. Screening mothers multiple times throughout well-child visit is
relevant and beneficial to identify postpartum depression and its persistence. There were some
mothers who declined screening, which indicates that there is a need to explore the mother’s
acceptability to be screened. This study implies that in order for screening to be effective among
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individuals identified with the risk of depression there must be a system in place to ensure
adequate follow-up.
Level II evidence.
Friedman, Rochelson, Fallar, and Mogilner (2016) conducted a quasi-experimental study
that examined the effects of educational sessions about postpartum depression and
modification of the electronic medical record on providers screening for postpartum depression.
The study was conducted in a pediatric office in East Harlem, where a large population of lowincome patients resided. An educational session was given to the physicians and pre- and postsurveys compared to comfort and self-reported screening. There were three groups that
received individual educational sessions regarding postpartum depression and screening. One
hundred charts were reviewed at three different time periods, prior to the education intervention,
after the educational intervention but prior to the EMR changes and after EMR changes. Withingroup 1, none of the mothers documented PPD screenings, group 2, 2 of the 100 (2%) mothers
were screened and neither screened positive, and group 3, 69 (74%) mothers were screened.
Within-group 3, the 69 mothers that were screened, seven (10%) screened positive. There was
a statistically significant difference between the groups. Compliance with providers increased
after educational pieces were provided. However, some providers felt uncomfortable with
screening mothers, due to the unfamiliarity of the screening tools and referral process. “The
mean score on a test of general knowledge of PPD increased from 55% in the pre-group to 70%
in the post group who attended the educational conference” (Friedman et al., 2016, p. 795). The
study concluded that PPD screens are valid and can be integrated within a well-child
appointment. The increase of knowledge allows pediatricians to have a better understanding of
the screening tools and its use, which essentially increases the actual screenings. This article
was well written and concise (grade B). The purpose was clearly stated, and data was
presented clearly throughout the article.
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Leis et al., (2014), conducted a pilot study that integrated an evidence-based preventive
intervention into a pediatric primary care clinic. The study took place in a low-income urban
community. The standard of care in this clinic included mothers bringing their infants for
newborn, 2-, and 4-month well-child visits was to meet with the clinical social worker for an
assessment of maternal health status and associated stressors using the USPSTF 2-item
depression screener. The inclusion criteria for this study included women who were
experiencing depressive symptoms and exclusion criteria included psychosis or significant
mental health impairment. After the selection of women for participation, two cohorts
participated in the MB Course. The MB Course is an intervention that uses cognitive-behavior
therapy approach to the management of moods by incorporating social learning concepts.
These concepts help reduce depressive symptoms. The intervention included 6 weekly, 2-hour
sessions. These 6 sessions were divided into 3 modules: (1) promoting pleasant activities, (2)
reducing harmful thought patterns and increasing helpful thought process and (3) promoting
social support. There was a total of 15 women who participated in the study, who enjoyed
participating in the study. Participants who attended a vast majority of the sessions showed
higher levels of engagement and accepted the intervention format and content presented. The
findings of this study indicated that implementing an evidence-based preventive intervention for
PPD in a pediatric primary care setting serving this particular population was successful. This
study was written clearly and appropriately (grade B). Authors clearly identified possible
outcomes and limitations to the study.
Van der Zee-van den Berg, Boere-Boonekamp, IJzerman, Haasnoot-Smallegange and
Reijneveld (2016) conducted a systematic review investigating the evidence of the effectiveness
of screening for postpartum depression in well-baby care settings, regarding mother and child
outcomes. The inclusion criteria and articles selected for review had great quality and were
assessed with the Quality Assessment Tool for Quantitative Studies. Some inclusion criteria
included women up to 12 months postpartum, screening using a valid screening instrument and
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articles written in English, Dutch, German or French. While some exclusion criteria include
studies with no control group to compare effectiveness, screening using a non-validated
instrumented, screening during pregnancy only and articles not written in other languages. From
these 3,033 articles screened six articles were selected. The article was well written and
organized (grade A) and the selected articles were explained in great detail. These six studies
were evaluated within this systematic review, of these six studies, two were rated strong pieces
of evidence and four were rated weak. The six selected articles range from a variety of study
designs, two being pre- and post- design with no blinding, one quasi-experimental and three
RCTs. After the assessment of the articles using the Quality Assessment Tool for Quantitative
Studies, overall the authors reported the articles to be strong to weak. From the studies, there
were four studies that supported the use of screening and enhancing care for postpartum
women. There were small sample sizes that made the evidence found relevant but not
significant, therefore higher-quality studies are needed to strengthen the evidence regarding the
benefits of screening in a well-baby care setting according to this review. Within this review,
multiple databases were searched, identified and details of the studies were presented. The
review was well written, and information flowed logically, and conclusions were based on the
results of the studies.
Level III evidence.
Waldrop, Ledford, Perry, and Beeber (2018) conducted an appraisal on current evidence
on implementing screening for postpartum depression within a pediatric primary care setting.
After a search in multiple databases using inclusion criteria such as dated after 2010 and
implementation of PPD screening in a pediatric primary care setting while exclusion criteria
included studies done outside of the United States, from this search a total of seven studies
were selected. These seven studies included one RCT, three quasi-experimental, two quality
improvement and one qualitative study. There were three screening tools used within these
studies, the Edinburgh Postnatal Depression Scale (EPDS), PHQ-2 and PHQ-9. The screening
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tool was provided during the intake process and a range of 27.8% to 78.8% of participants
completed the questionnaires. Within this appraisal, a description of the use of an algorithm for
screening is described and having supportive resources as well as a referral process in place
for practice. The authors of this appraisal identified the use of a clinical decision support
algorithm for screening and how its use is effective within the pediatric setting. “Using a decision
support algorithm that a pediatric primary care practice can adapt to fit its setting and needs is a
good place to start” (Waldrop et al., 2018, p.e70). This review concluded that the evidence
supporting the implementation and evaluation of PPD screening in a pediatric setting was
effective. The evidence was evaluated using the Grading of Recommendation Assessment,
Development and Evaluation (GRADE) criteria. These GRADE criteria measured the evidence
as moderate to low. This appraisal resulted in that screening for postpartum depression was
feasible to do at the local level. The purpose of this review was clearly stated and well written
(grade A). The search terms were clearly stated, and databases were indicated, the inclusion
and exclusion criteria were stated within the review and the flow of the studies reviewed was
concise.
Level IV evidence.
Rafferty, Earls, Yogman, and Mattson (2019) provided a screening recommendation
from the AAP stating that providers should screen women for maternal depression at well-child
visits. “Pediatric medical homes can establish a system to implement screening and to identify
and use community resources for the further assessment and treatment of the mother with
depression as well as for the support of the mother-child dyad” (Rafferty et al., 2019, p. 3). AAP
policy states there is much support for primary care pediatricians to incorporate these
approaches for implementing these screenings. The recommendations include the use of a
validated screening tool for maternal depression during well-child visits at 1, 2, 4 and 6 months.
There are also recommendations for follow up, referral processes and treatment options for
providers to follow to ensure the best patient outcomes are available for all patients. Within the
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statement, there are examples and resources for the providers to consider for their patients.
The clinical practice guideline is well written and relays information concisely (grade A).
Information is sponsored by a professional organization and has consistent and clear
recommendations. Utilizing clinical practice guidelines within the EBP project strengthens the
project and its support of implementation.
The AWHONN (2015) authored a position statement on mood and anxiety disorders in
pregnant and postpartum women. The statement recommends universal screening of all
pregnant and postpartum women for mood and anxiety disorders. Healthcare facilities that
serve pregnant women, new mothers, and newborns should have policies and protocols that
address screening and education for women and mechanisms for staff training regarding these
disorders. It is recommended that registered nurses are in key positions to recognize and
perform screenings to help identify at-risk women. Nurses can do so by providing initial effective
interventions, improving access to community-based resources and being the gap between
patients and healthcare providers. This position statement was well written and relayed
information concisely (grade B). This statement provides strength to the EBP project by
positively informing individuals of the need and importance of screening. With the support of a
professional organization, its recommendations are clear and specific.
Level V evidence.
Gyi (2018) conducted an evidence summary based on postpartum depression and the
best assessment tool for screening. This evidence summary based on a structured search of
the literature and steams from clinical practice guidelines, a systematic review and
observational studies. Guidelines recommend health professionals perform a routine
assessment of the emotional and wellbeing of women, while the systematic reviews assess the
accuracy of screening tools. These systematic reviews indicated that EPDS was the most
accurate and valid tool for screening. According to Gyi (2018), it is recommended that all health
care professionals involved with the care of the patient should assess for postpartum
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depression. Gyi (2018) provides a detail explanation of the proper assessment of postpartum
depression using the EPDS and the identification of scores. Individuals who score 10, 11 or 12
should be reassessed within 2-4 weeks and support services increased. Those individuals who
score 13 or 14 should be referred to an appropriate health professional. While individuals
scoring 15 or more should have access to a mental health assessment and management
immediately. Those individuals who score 1, 2, or 3 on question 10 should be assessed for the
safety of self as well as children in care. Gyi (2018) provides best practice recommendations for
health professionals to follow in order to care for postpartum women appropriately and
effectively. This evidence summary is written clearly and organized (grade A), recommendations
were clear, types of evidence were included, and literature was up to date. The evidence
obtained was consistent with other high-level studies and the source of information was
credible.
Gilbert, Balio, and Bauer (2017) summarized the current literature regarding the
responsibilities of providers, liabilities, and perspectives of providers within a pediatric setting
screening for postpartum depression screening. Gilbert, Balio and Bauer (2017) stated “the
guidelines call for (1) maximizing benefits while minimizing burdens (2) assessing the likelihood
of effectiveness, voluntariness of the interventions and distribution justice; (3) respecting patient
and parent autonomy, privacy and confidentially; (4) considering the responsibility and liability of
the provider; and (5) seeking input from all stakeholders “ (p. 269). The authors noted that there
is a burden placed on caregivers when screening is done alone. It is ethically imperative that
mothers who screen positive have an appropriate follow-up process for the support of both the
mother and infant. For pediatricians, there is a fiduciary duty to provide care for the children
beyond the child due to children not having the capability to speak for themselves and having
legal guardians. The literature supports a variety of terms in which the healthcare provider is
responsible to ensure patients are receiving the best care possible. These terms include
beneficence, non-maleficence, autonomy, informed consistency, confidentiality, privacy, utility,
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and distributive justice. Each of these terms was discussed within the literature and how
pediatricians have a legal obligation to provide the best care for their patients, which extends
beyond the actual patient themselves. Medical liability plays an important role in appropriate
care being given to patients. It hinges on if a provider is practicing responsible and consistent
with the standard of care. Screening mothers in a pediatric setting can be argued that the
pediatricians have an ethical responsibility to care for the mother who is caring for their patient.
The literature supports the use of a valid tool to screen postpartum women for postpartum
depression. The most common tool used for identifying symptoms was the EPDS and the PHQ2 or PHQ-9. Within these supporting literatures there is a strong legal and ethical case
supporting the implementation of a universal screening for PPD in a pediatric primary care
setting using validated tools when informed consent can be obtained and appropriate follow-up
services available and accessible. This review of the literature is well written and described the
aims in great detail (grade A/B). The strengths, limitations and future implications were
expanded upon clearly and concisely. There was no bias reported in the literature review noted.
Kurtz, Levine, and Safyer (2017) conducted a literature review addressing the concerns
of implementing postpartum screening within a pediatric primary care setting. Kurtz et al., (2017)
provide information regarding types of postpartum mood and anxiety depressive disorders
(PMADs), such as depression, baby-blues, postpartum depression, anxiety and postpartum
psychosis, and how they can impact an infant. The impact and management of each depressive
disorder are based on the severity of the mothers’ symptoms. The baby-blues seem to affect
between 15% to 85% of new mothers, while postpartum depression affects 10-20% of mothers.
Postpartum anxiety disorders affect between 11% to 21% of women while postpartum psychosis
occurs as high as 30%-50% of women. These depressive disorders are common postpartum
and can occur up to 1 year postpartum. These depressive disorders have different impacts on
the infant’s life based on the severity of the mothers’ symptoms, mothers with PMADs tend to
have lower levels of maternal sensitivity which can be neglected for the infant. PMADs have a
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negative impact on the mother-infant relationship which leads to a dysfunction of infant
development. Implementation of screening for postpartum depression is based on the individual
characteristics of the pediatric office setting. There are recommendations based on AAP, Bright
Futures, DC Collaborative for Mental Health in Pediatric Primary care and the Society for
Developmental and Behavioral Pediatrics (SDBP) Workgroup and state legislations. Kurtz et al.
(2017) recommend the Plan-Do-Study-Act (PDSA) cycle to implement practice change following
the evaluation of the special needs of each pediatric clinic setting. Screening mothers using the
EPDS, PHQ-2, and PHQ-9 was recommended based on the pediatric setting environment. The
study concluded that it is possible to implement the screening program within each practice to
better serve mothers and infants. The study was written well and reviewed the current literature
appropriately (grade B).
Olin et al., (2017) reviewed literature that suggested that there are specific strategies to
aid in the implementation of screening for postpartum depression within a pediatric setting. The
authors produced a stepped care approach to caring for screening and managing postpartum
depression. Step 1 included screening for depressive symptoms using either rather EPDS or
PHQ-9 to screen mothers in a pediatrics setting beginning at the 2-month well-baby visit through
the 6-month well-baby visit. These early screening measures can lead to early treatment of
postpartum depression. Step 2 included psychosocial risk assessment to understanding the
contributing factors leading to PPD. Targeting these contributing factors can aid in the
development of the support needed by pediatric providers. A risk assessment tool can be used
to assess perinatal risk for depression in primary care settings, which aids in the development of
screening tools postpartum. Step 3 detailed care management based on the risk profile for
women who fall in the middle section of the care pathway, with moderate levels of depression
symptoms. These women benefit from supportive interventions that can be integrated within the
well-child visit. Step 4 provided guidance for follow-up and monitoring of PPD, suggest following
up at the 6-month well-care visit for individuals who are high risk and that periodic reassessment
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is included, which entails life events that can affect maternal and child well-being. Maternal
depression can last up to one year postpartum, if unaddressed. Recognizing PPD risk factors
during well-child visits is important for continuous monitoring.
This stepped care approach includes systematic screening for depression symptoms,
and a systematic risk assessment for women who screen positive and care management based
on risk profiles and responsiveness. The literature concludes that the proposed pathway
(stepped care) is a testable model that can be integrated into a pediatric setting to improve child
well-being. There are challenges in implementing screenings in pediatric settings such as lack
of confidence and in effectively managing mothers, lack of reimbursement, social and
environmental factors, lack of supportive interventions, concerns of confidentiality and sensitivity
and provider documentation. These challenges are real but not insuperable. The review of
literature is well written, and information is relayed concisely (grade A/B).
Mgonja and Schoening (2016) implemented a quality improvement project to implement
and evaluate a postpartum depression screening program utilizing the EPDS within a pediatric
setting. During well-child appointments up to one year of age, mothers were screened for
postpartum depression at a private, faith-based primary care clinic in the Midwest. The authors
used the Plan-Do-Study-Act (PDSA) framework to guide their project. The EPDS was given to
mothers (ages 19 years or older) at well-child appointments, and results reviewed frequently to
incorporate protocol changes as necessary. Developing a care plan for mothers scoring of 10 or
higher was termed triage care and considered a positive result. There were a total of 35
mothers screened over 9 weeks. Staff compliance, which was calculated weekly, was 78.7% of
administering the screening tool, there were a total of 10 (21.3%) missed opportunities. Mothers
that were screened ranged from ages 20-34 years, while the infant ages range between 2
weeks to 12 months. Results indicated that there were five positive EPDS screenings during this
project implementation. The study concluded that screening mothers during well-child
appointments is appropriate and if not done is a missed opportunity for providers. This study

YOU’RE NOT FORGOTTEN

26

supports the use of implementing a screening tool within a pediatric setting to identify PPD at
well-child visits up to one year of age. This quality improvement project was written clearly and
examines the workflow and processes of incorporating the screening tool into a pediatric setting
(grade A). The aim of the project was stated clearly, and results were described and interpreted
clearly.
Puryear, Nong, Correa, Cox, and Greeley (2019), conducted a quality improvement
project that increases access to perinatal mental health services through a universal screening
tool for postpartum depression and facilitating referrals for evaluation and treatment at a multisite, integrated system of pediatric and obstetric practices in Houston, TX. Women were
screened with the EPDS twice during pregnancy and at 6 weeks postpartum by their obstetric
provider and at their infant’s 2 weeks, 2-, 4- and 6-month at well-child visits by pediatricians.
Women with a score of 10 or higher or women who reported thoughts of self-harm were offered
a referral to a mental health provider. A total of 102,906 women were screened over a four-year
period. Of those, 6,487 (6.3%) screened positive and with 3,893 (3.8%) referred for treatment.
From those referred for treatment, 2,172 (55.8%) women made an appointment with a mental
health provider within 60 days of the referral. 170 positive screens resulted in 185 (108.8%)
referrals with 153 (82.7%) appointments completed for one obstetric practice. The obstetric
practices with collocated referral model, 1,489 positive screens resulted in 2,222 (149.2%)
referrals with 1,702 (76.6%) completed appointments. The pediatric practice with adjacent
lactation of women’s clinic, 220 positive screens resulted in 96 (43.6%) referrals and 39 (40.6%
appointments completed. While the remaining pediatric practices had 4,608 positive screens
resulting in 1,390 (30.2%) referral sand 278 (20.0%) completed appointments. This quality
improvement project indicated with adequately trained staff and systematic planning that PPD
can be screened within both obstetric and pediatric practices and high screening and referral
rates can be achieved. This quality improvement was well written and relayed information
clearly (grade A). The aim of the project, strengths, limitations and results were clearly stated.
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Sorg, Coddington, Ahmed and Richards (2019) conducted a quality improvement project
to improve standardized screening for postpartum depression for a 3-month period in the
pediatric care setting in a rural federally qualified health care center (FQHC) in north-central,
Indiana. There were secondary aims to determine if infant and family characteristics were
associated with positive postpartum depression screening. This implementation of the EPDS
screening tool occurred at 1,2 and 6-month WCC visits and was evaluated by independent
samples t-test and logistic regression for data analysis. The EPDS was administered by the
nurse or medical assistant (MA), and then the PCP reviewed the results and implemented the
next step based on the score. The results were recorded in the electronic medical record (EMR)
by the nurse or MA, and the EMR scored the completed EPDS. This quality improvement
project was based on the PDSA framework and showed a slightly significant increase in PPD
screening practices with improvement from 83% to 88% (p= 0.096). This project indicated that
mothers who were screened at 1-month well child check (WCC) visits had higher rates than
mothers screened at 2 or 6- month WCC visits. Demographics such as male gender, Medicaid
and Hispanic ethnicity had a higher likelihood of positive screenings. Mothers who bottle-fed
versus exclusively breastfeed had a lower likelihood of positive screenings. Monthly income
affected positive screening rates, whereas mothers who earned less than $2,000 a month had
higher positive screening rates. This quality improvement project indicated that pediatric health
care providers can effectively screen for PPD and certain infant and family characteristics might
alert the provider to a higher risk for mothers. This quality improvement project was well written
and provided clearly stated aims and results (grade B). There was no bias reported in the
project.
Construction of Evidence-based Practice
Synthesis of Critically Appraised Literature
The appraisal of these fourteen relevant pieces of literature specified a deeper
understanding of implementing a screening protocol for PPD within a pediatric setting. Studies
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that were used within the appraised literature disclosed findings and recommendations for
practice in direct response to this project’s PICOT question. The literature evidence supporting
this project revealed comparable findings and recommendations for best practice (See Table
2.2). The use of the EPDS (intervention) to screen postpartum women presenting to the
pediatric setting for their infant’s well-child visits (population) was supported in the literature as
an effective way to identify PPD (outcome) in pediatric settings up to six months after delivery
(timeframe).
Population. The literature was divided when deciding to measure depression either in a
pediatric setting or an obstetric setting. The underlying goal across all of the studies was to
increase the use of PPD screening in a pediatric setting. All of the guidelines suggested
measuring depression prenatally and postpartum or anytime when in contact with a perinatal
mother (AWHONN, 2015; Gyi, 2018; Fafferty et al., 2019). With the assessment of mothers
postpartum, many studies implemented a protocol for measuring PPD within an urban setting to
explore any acceptability and outcomes (Friedman et al., 2016; Leis et al., 2015). While there
was implementation across urban settings, the literature did support implementing a protocol
within all pediatric areas, rather urban, rural, heavy populated or not (Puryear et al., 2019; Kurtz
et al., 2017; Gilbert et al., 2017; Olin et al.).
Interventions. The literature appraised suggested that there was an intervention tool that
would be best for use in a pediatric setting to screen for postpartum depression. A simple 10item self-report questionnaire, the EPDS was provided to all the patients who met criteria to be
screened prior to seeing the provider (Gyi, 2018; Emerson et al., 2018; Olin et al., 2017; Kurtz et
al., 2017; van der Zee-van den Berg et al., 2016; Waldrop et al., 2018; Sorg et al., 2019;
Puryear et al., 2019; Mgonja & Schoening, 2016). The evidence suggests that this screening
tool is the most effective and valid. Some pediatricians opted to utilize different screening tools
in combination with the EPDS such as the PHQ-2 or PHQ-9 (Waldrop et al., 2018; van der Zeevan den Berg et al., 2016; Kurtz et al., 2017; Gilbert et al., 2017; Olin et al., 2017).
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Length of intervention. The length of the intervention varied from eight weeks to four to
six months. The screening process for mothers had some consistency throughout most of the
studies, typically including screening at 2, 4 and 6 month well-child visits with some variations,
based on pediatric visits (Emerson et al., 2018; Olin et al., 2017; van der Zee-van den Berg et
al., 2016; Sorg et al., 2019; Puryear et al., 2019; Mgonja & Schoening, 2016). In addition, the
length of the intervention did not extend past 6 months due to 6 months being the peak of when
women experience PPD.
Best Practice Model Recommendation
The best practice model recommendation developed for this EBP project was
synthesized from the most current, best available and critically appraised evidence. Postpartum
women are not currently screened effectively due to the limited amount of time they visit with
their obstetrician. Women have only one or two postpartum visits with their obstetrician which is
a narrow window for screening, while “a pediatric primary care provider sees a mother as
frequently as eight times within the first 6 months of her child’s life, placing pediatric providers in
a strategic position to screen for PPD” (Waldrop et al., 2018, p.e68). Henceforth, postpartum
depression can negatively affect the mother’s engagement with others. “Postpartum depression
impacts not only the mother, but it also affects the family, most notably the infant. Untreated
PPD is associated with lower rates and shorter duration of breastfeeding, poor maternal-child
bonding, child and infant developmental delays and poor mental health outcomes in childhood”
(Sorg et al., 2019, p.84). Therefore, screening for postpartum depression in a pediatric setting
creates a destigmatizing opportunity for providers to ensure measures are being taken to
properly screen for mood disorders, closing the gap of mothers being overlooked for screenings.
Consequently, screening mothers in a pediatric setting using the EPDS was created as an EBP
project to link current evidence to practice and potentially impact all postpartum mothers during
well-child visits. This program was developed in a pediatric setting in a patient-friendly format
that can easily be implemented in other pediatric settings and aligns with recommendations
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from AAP, USPSTF, AWHONN, CMS, and National Association of Pediatric Nurse Practitioners
(NAPNAP). This author proposed that implementing the best practice model, You’re Not
Forgotten, would demonstrate that mothers participating in the screening process in a pediatric
setting would demonstrate positive shifts in knowledge and attitudes about post-partum
depression and seek treatment for postpartum depression following the program intervention.
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CHAPTER 3

IMPLEMENTATION OF PRACTICE CHANGE
Implementation of an evidence-based protocol including the use of a PPD screening tool
for the identification of postpartum depression in mothers visiting a pediatric office for well-child
visits was considered best practice by the current body of evidence reviewed in the literature.
Multiple expert organizational recommendations and position statements support this universal
practice change including the AAP, USPSTF, AWHONN, CMS, and NAPNAP. Therefore, this
evidence-based protocol was initiated as a result of an identified need and supportive evidence
demonstrating positive outcomes. The EBP project included the project coordinator’s
collaboration with pediatric office providers and staff who appreciate and value the significance
of practice change to improve patient outcomes. This EBP project aimed to help identify
postpartum depression in women who may not follow up with their obstetrician during the
postpartum period and/or were not screened appropriately in the obstetric setting when
returning for care post-delivery. The purpose of this project was to improve the identification
rates of postpartum depression by implementing a postpartum depression screening in a
pediatric setting during well-child visits.
Participants and Setting
The conduction of the EBP project took place in a pediatric office setting located in Fort
Wayne, Indiana that provides primary care services to patients across the lifespan of newborns
to early adulthood up to the age of 21. The pediatric office providers consisted of a double
board-certified pediatrician (MD), office manager, secretaries, a pediatric nurse practitioner
(NP), two physician assistants (PAs) and medical assistants (MAs) which will be a part of the
practice change. The project coordinator has never been employed by this facility, which aided
in eliminating the potential of selection bias. Written permission for the project’s implementation
was granted on June 19, 2019, by the facility’s office manager after discussion with the primary
physician of the practice, who was in full support of the project’s goals for practice change. Key
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stakeholders at the project site supported that the project would be beneficial for the patient
population, was feasible for the location of the facility, and staff within the clinic had a vested
interest in the project outcomes.
Participants eligible for participation in the project were mothers of infants recruited
during their well-child visit appointments at the 1, 2, 4 and/or 6-months visits at the pediatric
health center from September of 2019 to November of 2019. The secretaries’ role in the project
was to review patient charts at check-in to determine initial eligibility based on the type of visit.
Participants were postpartum women attending well-child visits that were 18 years or older that
have the ability to understand spoken and written English. Spanish assessment tools were
provided for patients whose primary language was Spanish but understood English.
Mothers with a positive history of depression, including currently being treated for
depression with pharmacological management, cognitive therapy and/or any homeopathical
alternatives were eligible for participation but this was disclosed upon the initial patient survey
questionnaire collected during recruitment. The decision to include these participants was made
by the project coordinator and site facilitator because it was determined that excluding these
patients would limit the sample size.
Pre-Intervention Group Characteristics
Participants eligible to participate were adult women, 18 years of age or older regardless
of race or socioeconomic status, presenting to the pediatric site during the months of September
to November of 2019 for their infant’s well-child visits. The participants were English and
Spanish speaking individuals, however, those individuals that spoke Spanish, had to
comprehend English in order to participate. The inclusion criteria included postpartum women,
attending well-child visits between 1, 2, 4, and 6 months at the pediatric health clinic. While
exclusion criteria included individuals under the age of 18, non-English speaking adults, and
males (fathers). These participants were excluded from the project due to the inability to
complete the activities required of the project.
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Intervention

After reviewing the recommendations from good and high-quality pieces of evidence,
the EBP project intervention was developed based on these best practice recommendations.
The most reliable and consistently recommended PPD screening tool to implement in the
pediatric setting was the EPDS. The literature supported the effectiveness of using this
screening tool to help providers identify the risk for postpartum depression. Each eligible
participant that consented to participate in the EBP project received an informed consent (see
Appendix D), a recruitment letter including a description of the project participant questionnaire
and the EPDS screening via paper and pencil format. Samples of the recruitment letter with the
project introduction is presented in Appendix D and the participant questionnaire is presented in
Appendix F. After the consent was signed and the screening tool results calculated by the
secretarial staff or medical assistants at the project site, the numerical results (ranging from 010+) of the EPDS was recorded in the patient’s EMR by the secretaries or medical assistants in
the PPD screening section of the chart for the provider to access during the well-child visits. All
participants with a score of less than 10 on the EPDS resulted in participants receiving
information regarding postpartum depression in the form of an educational handout (see
Appendix F) and provider discussion as documented in the EMR. A score of 10 or greater on
the EPDS resulted in participants receiving information regarding postpartum depression in the
form of an educational handout and provider discussion, a list of community resources, as well
as referral to their obstetrician or primary care provider for further management and care. When
present in the clinical setting, the project coordinator was available to answer questions that any
participants had regarding the project, while it was the responsibility of the providers within the
clinic to provide education and discuss the results of the screening tool with mothers during
well-child visits. The project coordinator reviewed the health records of participants to track
scores at each visit, ensured documentation and adherence to educational handouts and
discussions by providers as well as resource lists and referrals within the community. The

YOU’RE NOT FORGOTTEN

34

project coordinator conducted calls to all mothers that scored 10 or higher within 2 weeks of
their visit to track compliance with follow-up to referrals. A 12-week follow-up phone call was
made to re-evaluate all participants EPDS scores. A review of records as well as patient
schedules to evaluate missed opportunities and declination of participation by mothers asked to
sign consent was also conducted.
Comparison
The AAP recommends that pediatricians close the gap and initiate screening mothers
for maternal depression during well-child visits. Screening mothers at the first six well-child visits
increases the chance of a mother disclosing postpartum depression symptoms. The provider is
able to see consistencies in scores while tracking her progress within the electronic health
record. Compared to the current standard of care consisting of no routine or standardized
screening, documentation, education, or distribution of community resources or referral at the
pediatric health clinic, this project implementation adheres to best practice optimal mother and
baby outcomes.
Outcomes
Multiple outcomes of the EBP project were measured based upon the supporting
literature. The primary outcome measured was the effectiveness of the identification of risk for
postpartum depression in postpartum women using the EPDS in a pediatric setting during wellchild visits. While the secondary outcomes measures including demographic characteristics,
different variables that could potentially affect EPDS scores and pre- and post-intervention
EPDS scores in relations to follow up.
The secretaries were responsible for checking patients in and distributing the project
introduction letter, screening tool, and participant questionnaire. While the MAs were
responsible for the calculation and entering of the EPDS scores in the EMR. The providers were
responsible for the reviewing of scores and discussion/education patients and to distribute
educational handouts and resources/referral lists. The project coordinator was responsible for
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conducting follow up phone calls with participants scoring 10 or greater within 2 weeks to
monitor compliance with referral follow up. The project coordinator also called all participants for
a post intervention EPDS score at 12 weeks. The project coordinator was responsible for
reviewing chart records to track maternal EPDS score trends with WCC visits, missed
opportunities, declination of participation and provider adherence/documentation of score
review, discussion, education and referral as appropriate based on score.
Evaluation of the reported answers and referral process was based on best practice.
EPDS is a user-friendly tool that takes approximately 2- 5 minutes to complete with 10
questions presented with options in a Likert scale format. This Likert scale consists of each
question that can earn up to 3 points. The mother was asked to check the response that comes
closest to how she has been feeling in the previous seven days. There was a maximum score of
30 points. Scores ranging from 0-9 received PPD information and resources, scores 10 or
greater received a referral as well as resources and any mother scoring a 1, 2 or 3 to question
10 about suicidal ideation was assessed by the provider and referred out for immediate
assistance. Possible risk for depression was indicated with a score of 10 or greater, while
scores above 13 were likely to be suffering from a depressive illness of varying severity. This
screening tool provided the provider with a clear picture of the patient’s mental health status
over the 7 days preceding the well-child visit. The AAP does not endorse or approve any
specific tool for screening purposes but provides a resource for providers to use to select a
screening tool from screeningtime.org. This AAP (2019) authored website offers a variety of
resources to assist providers with the screening process for maternal depression,
developmental concerns, and social determinants of health. The EPDS tool has 86% sensitivity
and 78% specificity and can be completed in five minutes or less and scored three minutes or
less (AAP, 2019). Data was collected before the participant saw the provider upon check-in for
the appointment at the receptionist desk. Once signed in, the secretary or project coordinator
provided the mother presenting for 1, 2-, 4-, and 6-month child visits with a project packet
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including an introductory letter about the project, consent form, participant questionnaire, and
EPDS screening tool. Once the data form was collected by the MA, the total score and score for
question 10 were calculated with a key (see Appendix F) and results were recorded in the EMR
for the provider to see with a prepopulated algorithm to guide provider interventions. After the
results were recorded, patient names were removed from the form, a unique identifier was
assigned for data analysis and subsequent visit tracking and the form were kept in a secure
lockbox on site. The project coordinator collected forms weekly to properly analyze the data.
Measurement. Frequencies and descriptive statistics were conducted to evaluate the
demographics of mothers and their scores on the form, the credentials of certain providers (NP,
PA, or MD) and their adherence to documentation, discussion, etc. with patients about their
EPDS scores. A paired sample t-test was conducted to evaluate the EPDS scores prior to
implementation and 12 weeks post-intervention.
Time
This EBP project was implemented from September 3 rd through November 26th of 2019
based on the recommendations from the project site facilitator and correlating academic session
of the University in which the project coordinator was enrolled. These dates were prior to the
winter months, in which staff and/or patients and families may take a vacation, inclement
weather could increase the likelihood of missed appointments and holidays may have impacted
the office hours of the clinic. Literature shows that data can be collected anywhere between 8
weeks to 6 months (Kurtz et al., 2017; Rafferty et al., 2019; Sorg et al., 2019; Emerson et al.,
2018). Proper implementation of this intervention required at least 60 days which was
recommended by the project facilitator and office staff. This timeframe ensured that staff were
adaptive to the changes and incorporated the PPD screening recommendation within their daily
routines. Planning for this timeframe requires staff education and training, printing preparations,
EMR familiarity, templating, and staff participation.
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Protection of Human Subjects

The protection of human subjects was maintained throughout the EBP project. The
project coordinator was educated regarding the protection of human subjects and successfully
completed an ethics course within the Valparaiso University Doctor of Nursing Practice (DNP)
curriculum in the fall semester of 2017. Online training was also completed through the
Collaborative Institutional Training Initiative (CITI) in April of 2019. A certificate of completion of
the CITI course is available in Appendix B. The project coordinator received approval from the
Valparaiso University Institutional Review Board (IRB) through an exempt review as a quality
improvement project on July 21, 2019. Consent was obtained from participants (see Appendix
D) and a thorough written explanation of the project, including the risks, commitment, and
benefits, was provided to each participant. Confidentiality was also upheld, and participants
were made aware that participation was solely voluntary. No pressure or coercion was involved
for participation. The data collected was kept in a secured and private location and identifiable
information was removed from the form with unique identifiers assigned for data tracking and
analysis (see Appendixes D-E).
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CHAPTER 4
FINDINGS

You’re Not Forgotten was developed to provide an evidence-based approach to aid
pediatric healthcare providers in identifying the risk of postpartum depression in women who
were attending well child visits with their infants. This approach helped identify women who may
have gone unscreened from missed visits with their PCP or OB/GYN during the postpartum
period. To address the issue, the project coordinator developed a 12-week EBP project. The
EBP project was designed to determine if screening mothers for PPD using a standardized tool
in a pediatric setting would better identify those at risk of developing PPD. This would promote
earlier pediatric provider screening and treatment interventions for women with PPD who could
possibly be missed otherwise. Primary patient outcomes, including the depression screening
scores were measured via the EPDS over a 12-week period. Secondary outcomes, including
participant demographics, variables that could potentially affect EPDS scores, and the pre- and
post-intervention EPDS scores in relation to follow-up.
Participants
During the time of project implementation, 40 postpartum women presenting to a
privately-owned pediatric clinic located in northeastern Indiana were eligible to participate in the
project. Of the 40 eligible postpartum women, 37 consented to participate by completing the
patient data form and the self-reported depression EPDS screening. However, only 30 women
completed and submitted the questionnaire that included the patient data form and selfreporting depression EPDS screening in its entirety. Seven women failed to submit the
completed questionnaire or submitted an incomplete questionnaire to office staff and were
excluded from further data analysis. As a result of the screening intervention, five women were
referred to their OB/GYN or PCP due to their high risk for PPD identified on the EPDS with total
scores greater than or equal to 10. During project implementation, all providers (physician, NPs
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and PAs) understood the importance for practice change and eagerly participated in the
process.
Demographic characteristics for participants (N = 30) were analyzed using frequency
statistics. Participants infant ages ranged from 1 month to 6 months with 33% of ages being 2
months. The majority of participants were Caucasian (60%), reported having achieved an
educational level of a high school diploma (56.7%) and earned an annual income of less than
$25,000 (76.7%) (see Table 4.1). The majority of participants reported no significant past
medical history, including any mental health disorders (60%) while the remaining 40% did report
a history of a mental health disorder. There were 23.3% participants who received previous
treatment but 76.6% denied previous treatment for any psychological conditions and had
followed up with their OB/GYN for a medical examination during the postpartum period (56.7%)
(see Table 4.1).
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Table 4.1
Demographic Characteristics

Demographics

Frequency

Percentage

Number of participants

30

100%

Baby Age
Mean/SD
1 Month
2 Month
4 Month
6 Month

2.6333/1.62912
9
10
8
3

30%
33.3%
26.7%
10%

Race
African American
Caucasian
Hispanic
Asian
Other

7
18
5
0
0

23.3%
60%
16.7%

Yearly Income
Less than $25,000
$25,000-$49,999
$50,000-$74,999

23
5
2

76.7%
16.7%
6.7%

Highest Education
Elementary
High School
Some College
College Graduate

0
17
4
9

56.7%
13.3%
30%

Medical History
Depression
Postpartum Depression
Anxiety
Multiple History
None

3
2
1
6
18

10%
6.7%
3.3%
20%
60%

Current Treatment
Treatment
No Treatment

7
23

23.3%
76.7%

Type of Treatment
Medications
Therapy
No Treatment

7
0
23

23.3%
76.7%
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Table 4.2
Demographic Characteristics

Demographics

Frequency

Percentage

Follow up with OB
Yes
No
No answer

17
12
1

56.7%
40%
3.3%

Follow-up Weeks Postpartum
1-2 Weeks
3-4 Weeks
5-6 Weeks
7+ Weeks
No answer

1
2
14
1
12

3.3%
6.7%
46.7%
3.3%
40%

Provider at Time of Visit
MD
PA
NP

5
11
14

16.7%
36.7%
46.7%
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Figure 4.1. Infant ‘s Age
1 Month

2 Months

4 Months

6 Months

10%

30%

27%

33%

Figure 4.2. Mom’s Race
African American

Caucasian

Hispanic

17%
23%

60%
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Figure 4.3. Yearly Income
Less than $25,000

$25,000-$49,999

$50,000-$74,999

7%

17%

76%

Figure 4.4. Highest Educational Level
High School

Some College

College Graduate

30%

57%

13%
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Figure 4.5. Medical History
Depression

Postpartum Depression

Anxiety

Multiple hx.

10%
7%
3%

60%

20%

Figure 4.6. Follow-up with OB/GYN or PCP
Yes

No

No answer

3%

40%
57%

None
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Figure 4.7. Provider at Time of Visit
MD

PA

NP

17%

46%

37%

YOU’RE NOT FORGOTTEN

46
Changes in Outcomes

You’re Not Forgotten EBP project addressed the following PICOT question, “In
postpartum women (P), how does the implementation of a screening and referral protocol (I) for
postpartum depression in a pediatric setting affect mental well-being (EPDS scores) (O), as,
compared to the current practice (C) over a twelve-week period (T)?” The primary outcome of
risk for PPD was measured in participants using the EPDS at baseline during the 1, 2, 4 or 6
months well child visit and again at 12 weeks post-intervention. Secondary outcomes, including
participant demographics, different variables that could potentially affect EPDS scores and the
pre and post-intervention EPDS scores in relations to follow-up.
Statistical Testing and Significance
Data was inputted into the Statistical Package for Social Sciences (SPSS) version 25
software for analysis. The textbook entitled How to use SPSS: A step-by-step guide to analysis
and interpretation by Cronk (2017) was used to guide the progression of data analysis and
interpretation. With the guidance of a statistician student, a paired-samples t-test was used to
compare the means of participant pre-and post-intervention EPDS scores. Participant
demographic data was measured via frequency statistics. A one-way Analysis of Variance
(ANOVA) test was conducted to identify project variables in relation to the effects on EPDS
scores.
Findings
Project findings indicated that there was significance with the overall primary outcome of
participant EPDS scores pre- and post-intervention. Statistical significance was set at p < .05 for
all analyses. Based on the analysis between variables measured there was a concession of
significance and no significance in relation to the results of the EPDS scores. A Cronbach’s
alpha was conducted to test reliability and validity of the EPDS screening tool and was found to
be .855, which demonstrates good reliability and validity.
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Primary outcome. The primary outcome of You’re Not Forgotten was to implement a
PPD screening protocol within a pediatric setting. Doing so aided in the identification of at-risk
mothers for PPD and providing educational information and a rescreening process to continue
to monitor their mental health. The EPDS screening tool was utilized to identify women who
were at risk for PPD. Participants were asked to rate their feelings over the past seven days
using a 10-item Likert scale. The responses on the EPDS instrument were summed into a total
scored which identified if the participant was at high risk for PPD at two different intervals over a
12-week timeframe. Total EPDS scores ranging from 0-9 were considered lower risk for PPD
and scores of 10 or greater were considered at high risk for PPD. Furthermore, positive answers
to question number 10 on the EPDS tool prompted immediate medical attention. A pairedsamples t-test was calculated comparing the mean of the pre-intervention EPDS total score to
the mean of the post-intervention EPDS total score. The mean on the pre-intervention EPDS
total score was 4.83 (4.65), and the mean of the post-intervention scores was 2.40 (3.54). A
significant decrease from pre-intervention EPDS total score was found t(29) = 6.625, p < .001
(see Table 4.3).
In additional to the paired-samples t-tests that were calculated for the EPDS total scores,
paired-samples t-tests were also calculated for each individual item within the EPDS screening
tool pre-intervention and post-intervention (see Table 4.3). Each question was scored based on
the response of the participant, ranging from 0 to 3 scores, with a maximum of 30. A negative
response was scored as 0, while a positive response was scored as either 1, 2, or 3 for
questions 1, 2 and 4. While questions 3 and 5-10 were reversed-scored (see Appendix F).
Question 1 “I have been able to laugh and see the funny side of things” mean was 0.03 (0.18)
t(29) = 1.000, p > 0.05, Question 2 “I have looked forward with enjoyment to things” mean was
0.07 (0.05) t(29) = 1.439, p > 0.05, Question 3 “I have blamed myself unnecessarily when things
went wrong” mean was 0.47 (0.63) t(29) = 4.065, p < 0.05, Question 4 “I have been anxious or
worried for no good reason” mean was 0.50 (0.73) t(29) =3.746, p < 0.05, Question 5 “I have felt
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scared or panicky for no very good reason” mean was 0.30 (0.53) t(29) = 3.071, p < 0.05,
Question 6 “Things have been getting on top of me” mean was 0.47 (0.68) t(29) = 3.751, p <
0.05, Question 7 “I have been so unhappy that I have had difficulty sleeping” mean was 0.20
(0.47) t(29) = 2.693, p < 0.05, Question 8 “I have felt sad or miserable” mean was 0.27 (0.45)
t(29) = 3.247, p < 0.05, Question 9 “I have been so unhappy that I have been crying” mean was
0.13 (0.35) t(29) = 2.112, p < 0.05 and Question 10 “The thought of harming myself has
occurred to me” mean was 0.10 (0.31) t(29) = 1.795, p > 0.05. There was no significant
difference in questions 1, 2 or 10, while the remaining questions had a significant difference in
the responses pre and post-intervention.
Secondary outcomes. Secondary outcomes included analysis of general demographics
and sample characteristics, the relationship between pre- and post-intervention EPDS scores
and participant follow-up, as well as relationships among variables and EPDS scores. The
participants (N = 30) were a diverse group of women ranging from different ethnicity
backgrounds, social economic standing and education. Among this diverse group there were
23.3% (n = 7) African Americans, 60% (n = 18) Caucasians and 16.7% (n = 5) Hispanics (see
Table 4.1; also see Figure 4.2). Within this group 76.7% (n = 23) reported an annual income of
less than $25,000, 16.7% (n = 5) had an income between $25,000-$49,000 and 6.7% (n = 2)
earned between $50,000-$74,999 (see Table 4.1; also see Figure 4.3). With a variety of yearly
incomes, highest educational level attained was also evaluated which ranged from high school
graduate to college graduate. There was 56.7% (n = 17) of participants who graduated from
high school, while 13.3% (n = 4) had some college education and 30% (n = 9) obtained a
college degree (see Table 4.1; also see Figure 4.4). There was some medical history included
in the demographic data collection to help support project implementation and success (see
Table 4.1) including past medical history relating to mental health (see Figure 4.5) and
treatment and follow up with an OB/GYN or PCP (see Figure 4.6) pre- and post-intervention.
There were 40% (n = 12) of participants that reported having some history of mental disorder
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and of those, 23.3% (n = 7) were treated with psychiatric medications. Of all of the participants
(N = 30), 56.7% (n = 17) followed up with their OB/GYN or PCP during the postpartum period.
The relationship between the pre- and post-intervention EPDS total scores and follow up
with OB/GYN or PCP indicates that receiving educational information as a result of the project
intervention impacted the participants’ follow-up practices. A paired-samples t-test was
calculated to compare the mean of the pre-intervention EPDS score to the mean of the follow up
with OB/GYN or PCP, as well as the mean of the post-intervention EPDS score to the mean of
the follow up with OB/GYN or PCP. The mean of the pre-intervention EPDS score was 4.83
(4.65) and the mean of the pre-intervention OB/GYN or PCP follow-up was 2.67 (0.76). A
significant decrease from the pre-intervention EPDS score to follow-up was found t(29) = 2.259,
p < 0.05. While the mean of the post-intervention EPDS score was 2.40 (3.54) and the mean of
the OB/GYN or PCP follow-up was 2.67 (0.76). No significant difference from post-intervention
EPDS scores to follow-up was found t(29) = -0.348, p > 0.05.
Lastly, the effect of certain demographics on EPDS scores was a secondary outcome
measured. The different demographic variables (race, yearly income, baby’s age, education
level and medical history) were evaluated using a one-way ANOVA. A one-way ANOVA
comparing the postpartum mother’s baby’s age to the EPDS score was conducted. There was
not a significant effect on the postpartum mothers’ baby’s age on total EPDS score at the p <
0.05 level for these conditions F(3,26) = 1.798, p > 0.05. Postpartum women who began the
intervention when their baby was 1 month old scored a mean EPDS of 3.56 (3.84), 2 months old
mean EPDS of 4.50 (4.88), 4 months old mean EPDS of 7.75 (4.83), and 6 months old mean
EPDS of 4.83 (4.65). A one-way ANOVA comparing the participant’s race to the total EPDS
score was conducted and there was no significant effect found F(2, 27) = 0.397, p > 0.05.
Participants who were African American had a mean of 4.71 (5.06), those who were Caucasian
had a mean of 5.33 (4.93) and those who were Hispanic had a mean of 3.20 (3.27). A one-way
ANOVA comparing the participant’s yearly annual income to the total EPDS score was
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conducted and there was no significant effect on the yearly annual income on total EPDS
scores at the p < 0.05 for these conditions F(3, 27) = 1.403, p > 0.05. Participants who made
less than $25,000 had a mean of 4.91 (4.69), those who made between $25,000 and $49,999
had a mean of 6.40 (4.62) and lastly those who made between $50,000 and $74,999 had a
mean of 0 (0). A one-way ANOVA comparing the participants highest educational level achieved
to EPDS scores was conducted and there was no significant effect on the highest educational
level achieved on total EPDS scores F(2,27) = 1.787, p > 0.05. The participants who graduated
high school group mean was 5.88 (5.07), those who had some college experience had a mean
of 5.75 (5.06) and those who graduated from college mean was 2.44 (2.88). Finally, a one-way
between subjects’ ANOVA was conducted to compare the effect of past medical history on
EPDS total scores. There was a significant effect of past medical history on EPDS total scores
at the p < .05 level for the three conditions F(4, 25) = 3.121, p = 0.033. Post hoc comparisons
using the Tukey’s range test, also known as the honestly significant difference (HSD) test,
indicated that the mean score for depression, M = 11.33 (.58), was significantly different than
postpartum depression, M = 4.50 (6.36), and other variable outcomes M = 7.00, (6.63). Taken
together, these results suggest that history of past medical disorders have an effect on EPDS
total scores. Specifically, the results suggest that those who have suffered from any mental
health medical disorder are at a higher risk for PPD.
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Table 4.3
Edinburgh Postnatal Depression Screening Individual Results

Edinburgh Postnatal Depression Screening Results
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CHAPTER 5
DISCUSSION

The results of You’re Not Forgotten EBP project provide direction for providers to screen
for postpartum depression within a pediatric practice. The EBP project was intended to answer
the following PICOT question, “In postpartum women (P), how does the implementation of a
screening and referral protocol (I) for postpartum depression in a pediatric setting affect mental
well-being (EPDS scores) (O), as, compared to the current practice (C) over a twelve-week
period (T)?”. The project examined the impact of the use of postpartum depression screening
tools such as the EPDS tool to screen mothers during well-child visits to heighten awareness
and identification of postpartum depression and mental wellbeing of mothers. This chapter will
provide enlightenment and clarifications of the EBP project findings as well as provide an
evaluation of the applicability of the EBP model used to guide this project. Strengths and
limitations to the project will be discussed as well as implications for future practice, education,
and research.
Explanation of Findings
Project findings support the use of an effective postnatal depression screening tool
within a pediatric setting. Such results were consistent with current evidence-based supportive
literature. Project outcomes, including demographic characteristics and intervention data will be
discussed. Outcomes including pre and post-intervention EPDS scores and the relationships
between demographic characteristics and EPDS scores will be expanded upon. Additionally,
participant adherence to follow-up recommendations provided during the intervention will be
reviewed.
Participant findings
Based on the information reported in the current literature a larger sample size was
expected for this quality improvement project. The sample size for this project was limited for
several contributing factors. These contributing factors included a limited intervention timeframe
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as designated by the University where the project coordinator was enrolled and missed
opportunities for screening within the practice. The intervention time frame of 12-weeks was not
long enough to gather a large sample size, whereas supporting literature collected data for
longer periods up to six months post-partum. Missed opportunities occurred due to the
busyness of the clinic, increased workload of providers, and the project coordinator’s inability to
be in the clinic daily for optimal recruitment of participants.
Sample characteristics were as anticipated by the project coordinator including a
population of completely female (100%) participants 18 years of age and older presenting to a
pediatric office during the postpartum period. The majority of participants made less than
$25,000 (76.7%) annually, which is below the median household income in northeast, Indiana
(United States Census Bureau, 2018). Although the relationship between socioeconomic status
and risk for PPD (EPDS scores) did not demonstrate significance in this project, evidence
supports that those who earn less than $2,000 ($24,000/year) a month are at a higher risk for
PPD (Sorgi, Coddington, Ahmed & Richards, 2019). Research also supports that postpartum
women of low socioeconomic status are more likely to screen at high risk for PPD (Leis et al.,
2014; Friedman, Rochelson, Fallar & Mogilner, 2016). Demographic characteristics of
participants from this project are consistent with the literature, indicating that participants who
scored at high-risk for PPD (EPDS total score  10) earned less than $25,000 annually.
Furthermore, another known contributor to socioeconomic status is educational level. Within this
project, participant’s annual income correlated with their educational level. The majority of
participants graduated with a high school diploma (56.7%) while only 43.3% either attended
college or had a college degree. There was no relationship identified between education, or lack
thereof, to EPDS total scores.
There were three main ethnicities represented within the project, African American
(23.3%), Caucasian (60%) and Hispanic (16.7%). For this pediatric clinic, the project’s diverse
sample was a good representation of the population frequenting the office for routine care. The
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diverse ethnic backgrounds of the participants (N = 30) did not demonstrate a significant
difference in their risk for PPD. Although a relationship between the project participants’
ethnicity and PPD was not found, researchers have reported that Hispanics are more likely to
have positive PPD screenings (Sorgi, Coddington, Ahmed & Richards, 2019). Mothers
participating in this study were recruited during well-child visits ranging from 1 month to 6
months old, with the majority captured at the 2-month (33.3%) appointments. While there was
no significant difference between the infant’s age and their mother’s EPDS scores in this
project, Kurtz, Levine and Safyer (2017) discuss how the mother-infant relationship is impacted
depending on the severity of the mothers’ symptoms. Other researchers have reported that
mothers are more likely to screen positive for PPD at older well-child visits (i.e. 6 months)
appointments rather than younger well-child appointments (i.e. 2 months and 4 months)
(Emerson, Matthews & Struwe, 2018). On the contrary Sorg, Coddington, Ahmed and Richards
(2019) found that mothers who were screened at 1-month well-child appointments were at
higher risk for PPD than at 2- and 4-month appointments. Consequently, screening for PPD
throughout the infant’s entire first year of life increases the probabilities of identifying positive
(EPDS total score  10) EPDS scores.
Lastly, each participant in this project identified whether they have had any past or
current history of a mental health condition. There was a total of 12 (40%) participants that
identified having a positive history of a mental illness. Within this sample subset, half expressed
having multiple mental illnesses including depression, postpartum depression and/or an anxiety
disorder. Kurtz, Levine and Safyer (2017) suggest that those suffering from mental illnesses
have a higher chance of screening positive for PPD than those without, which can negatively
impact the infant’s health. Within this project, there was a significant association between a
reported history of mental illness and high-risk EPDS total scores. Thus, screening women who
have a past medical history of a mental health disorder for PPD during the postpartum period is
of the utmost importance.
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EPDS scores & follow up
During the implementation process of the project, participants were screened for their
risk for PPD during their infant’s well-child visits and received a 12-week follow-up phone call for
re-screening by the project coordinator following the intervention. Five participants met the
criteria outlined within the EPDS screening tool (EPDS total score  10) for referral to their
OB/GYN or PCP based on their initial screening results. During this 12-week implementation
process, the project coordinator evaluated participants EPDS total scores pre-intervention,
compliance of referral and post-intervention EPDS total scores. There was a significant
difference between the initial pre-intervention EPDS scores, and post-intervention participant
follow up with OB/GYN or PCP. The relationship between initial pre-intervention EPDS total
scores and post-intervention follow up with an OB/GYN or PCP indicates that those that needed
to follow up with their providers did so with success. Although there was a significant difference
between the pre-intervention EPDS scores and follow-up, there was not a significant difference
between post-intervention EPDS scores and follow up. These findings indicate that participants
that followed up with their OB/GYN or PCP did not have an impact on their post-intervention
EPDS scores. Though there was not a significant difference, each participant (n = 5) that
screened positive on the pre-intervention screening, screened lower than their initial score on
the 12-week follow-up.
Pre- & Post-Intervention EPDS scores
The primary outcome of this project was to determine if screening for PPD within a
pediatric setting is effective at identifying at-risk mothers during well-child visits. The paired
samples t-test indicated that there was a significant decrease (p < .001) in EPDS scores from
pre-intervention to post-intervention. The mean of the pre-intervention EPDS score was 4.83
while the mean of the post-intervention EPDS score was 2.40, which is a difference of 2.43.
These results imply that participants scored lower on their post-intervention screening than their
initial pre-intervention screening (Table 4.2) After participants received PPD educational
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information, discussion with their child’s pediatric provider about PPD and their risk for the
condition, follow-up with their OB/GYN or PCP, and a follow-up phone call with project
coordinator occurred. These interventions likely increased the management of their PPD risk
which was reflected in their 12-week post-intervention EPDS total scores. At the 12-week postintervention follow-up, 23.3% of participants verbalized the use of medication to help manage
PPD.
Strengths and Limitations of the DNP Project
Overall, the main objectives of this EBP project and successful implementation of the
planned interventions were accomplished. Although there were a variety of strengths noted
throughout this project there were also some limitations identified. Identifying and addressing
each strength and limitation aides in the facilitation of best practice in the identification and
management of postpartum depression.
Strengths
A strength of the project was the follow-up protocol set in place for participants who
scored positive (EPDS total score  10) on the EPDS screening tool. There was a 2-week
follow-up phone call conducted by the project coordinator for those who scored positive to
ensure they received the necessary support and management for their level of PPD risk. This
follow-up phone call allowed participants the opportunity to provide feedback about the
screening process and provide data post-intervention to calculate their PPD risk. Another
strength identified during project analysis included the benefit of providing PPD education and
resources to participants. Educational and resource materials administered during project
implementation heightened participant awareness of PPD and their potential risk for the
condition, especially because many of the participants were not screened prior to the visit to
their pediatrician’s office. Engaging participants with a list of supportive local resources for PPD
ensured that they had the information necessary to seek assistance and medical intervention if
desired. These resources included free counseling centers and low cost/ noninsured centers for
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the public. These resources provided the participants with an alternative to visiting their
OB/GYN or PCP, which could essentially reduce costs for treatment or therapy and be more
convenient for participants to utilize. Utilizing the ACE Star Model was a great strength for this
project by providing guidance for the development, implementation and evaluation of the
project. Applying the five different stages of knowledge transformation into the project
implementation, made transitioning research into practice at the project site practicable.
Moreover, the uniqueness of the model helped create new knowledge within the project site for
providers and participants.
Limitations
A small sample size was identified as a limitation to this project which resulted from the
recommended participant population by the AAP as well as the site facilitator’s time constraints
for recruitment and implementation. The intervention timeframe limited the sample size due to
the short amount of time to gather information, whereas AAP recommends participants being
screened during all of the well-child visits within the first year of an infant’s life. Participants were
recruited when presenting to the clinical setting for their child’s well-child visit during the
postpartum period. Project recruitment was low due to a turnover in staff at the clinic site
causing an increased emphasis on training new staff and reduced efforts at promoting the
project. Recruitment of participants and implementation of the project interventions were best
facilitated when the project coordinator was present in the clinic setting during two days each
week and responsible for these activities. However, it was not feasible for the project manage to
be present in the clinic on a daily basis and therefore it is likely that the recruitment efforts were
not adhered to as well by healthcare providers during the project coordinator absence. Because
providers were busy during the project implementation timeframe, it is likely that some potential
participants were missed on the days that they were responsible for recruiting participants. The
sample size was also limited by excluding adolescent mothers younger than 18 years of age
and fathers of infants. Finally, the follow-up and recording of mother EPDS scores within the
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EMR of their child at the clinic site by the providers was not completed as planned. The lack of
compliance by the healthcare providers in documenting this information may be attributed to the
overall large volume of patients encountered on a typical day and limited time for visits.
Furthermore, a new EMR system was launched simultaneously with project implementation
further complicating this process. As a result, the MAs provided PPD education and community
resources information to the participants and informed the healthcare providers verbally of the
mother’s EPDS total score prior to the well-child visit. This lack of formalized process for
documenting mother’s EPDS total score had weaknesses which can contribute to human error.
The reporting MA could notify the healthcare provider of the wrong results, provide the results to
a different participant or interpret the results incorrectly. This can be improved by utilizing a
completely electronic process including the EPDS screening tool being in electronic format that
automatically inputs data and scores into the well-child visit chart. This can help eliminate
human error and provide a more accurate result.
Implications for the Future
The You’re Not Forgotten project provided prodigious information for APRN profession in
relation to screening mothers at risk for PPD within a pediatric setting. Future implications for
practice, theory, research and education will be explored here. These implications can be used
to guide future EBP projects as well as address the stigma associated with depression and
mental health disorders among our society.
Practice
Current high-quality literature suggests that screening mothers for PPD within a pediatric
setting is best practice. Although it is expressed to be best practice, unfortunately many
pediatric offices are not implementing this practice. This project allowed for PPD screening to
become a part of the standardized practice at the project site in hopes that this could provide
support for all pediatric offices to adopt this protocol. The project intervention was very feasible
and cost-effective for the pediatric site. There was no expense to the pediatric office in regard to
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the postpartum depression screening tool since the project coordinator covered all printing
finances. Therefore, additional planning would be necessary to determine how patients will have
access to the screening tool and whether an electronic or paper format would be considered for
future practice. Potential options for EPDS screening at the project site in the near future that
providers at this setting have discussed include an electronic version of the screening tool with
pre-existing tablets utilized by the office for patients and/or the printing of a free version of the
screening tool from online resources. The electronic version of the screening tool will go directly
in the infant’s chart, while a paper form will be scanned into the chart and the actual form
destroyed. Sustainability is being considered for an electronic version, which will be completed
during well-child visits up to 12 months and recorded by the mother on tablets located in exam
rooms.
For future EBP projects related to PPD screening within a pediatric setting, larger
participant sizes, longer implementation times, and more detailed follow-up on the referral
process for mothers at risk would be beneficial. Additional recommendations for future projects
include following participants consistently throughout the project at multiple intervals over a
longer course of time. This would aide in the ability to properly track participants over a 6-month
period with each well-child visit to ensure effectiveness of screening within a pediatric setting.
Theory
The ACE Star Model was determined to be a good fit for this EBP project. Although the
project coordinator was a novice at implementing new knowledge/protocols within a practice,
the five stages of the ACE Star Model aided in the guidance of achieving successful practice
changes by helping overcome challenges that accompany change. The ACE Star Model
encompasses five stages: discovery research, evidence summary, translation to guidelines,
practice integration and process, and outcome evaluation (Melnyk & Fineout-Overholt, 2015).
Each stage was utilized and relevant to the project development, implementation and
evaluation. The foundation of the EBP project was essentially formed using the discovery
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research stage, by inquiring what practice change was needed and to conduct a literature
search. Recently having experienced childbirth and caring for an infant, the project coordinator
realized screening for PPD was commonly only performed at the 6-weeks follow up postpartum
visit with an OB/GYN. After questioning what happens to mothers who have PPD symptoms
well after 6 weeks postpartum and pondering if anyone would notice, the project coordinator
found strong evidence supporting the need for a change. Upon further investigation on the topic
a lack of awareness and follow-up/referrals was also noted to be a problem. Evidence was
reviewed during the evidence summary stage of the model, which indicated good and high
quality/levels of evidence to support the project. During these stages as well as the translation
to guidelines stage, the project coordinator determined how to properly utilize the supporting
evidence in a beneficial manner manager for patient outcomes.
There were modifications that occurred during the practice integration and change
process of the ACE Star Model. For example, the project coordinator initially wanted screening
to be done electronically to reduce the chance of error, but the project site was unable to
account for electronically screening participants. It was originally planned for the participants to
use a tablet to complete the EPDS screening and the score was to automatically translate to
their child’s EMR. Due to the EMR system changes prior to implementation accommodations to
utilize the paper form were made. Another modification that occurred during the practice
integration phase of the project was the utilization of the secretarial staff to recruit eligible
participants rather than the healthcare providers as initially planned. This modification benefited
the project by reducing missed opportunities. Having the secretarial staff provided the
screenings, aided in the reduction of missed opportunities but did not eliminate missed
opportunities. The secretarial staff deem to be more suitable to provide the PPD screening
along with other office paperwork.
During the evaluation stage of the ACE Star Model it was very helpful to revisit the goals
of the project and adoption of the practice protocol. Overall, the project was implemented with
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minimal modifications while still achieving the outcomes desired. After completion of the
implemented protocol, adoption of the project was discussed with the project site facilitator. As a
result, strategies for incorporating the EPDS screening tool within the EMR are being
considered. In congruency with the guidelines provided by AAP, it was discussed that the best
way to adopt this protocol would be to screen participants at well-child visits up to a year of the
infant’s life and provide participants with PPD education and community resources. Resources
will be provided to participants based on the provider’s discretion. Future plans may include all
parents (male or female) included in the screening during well-child visits at all pediatric
facilities. Future research is needed for screening protocols for the lesbian, gay, bisexual,
transgender and queer (LGBTQ) community and other legal guardians’ situations (i.e. adoption
and fostering). Considerations for future implementations at the pediatric project site include
strengthening OB/GYN and pediatrician relationships.
Research
Further research is needed to explore the effects of screening for PPD in a pediatric
setting in comparison to standard practice of screening in an OB/GYN or PCP office. It may be
that screening for PPD in a pediatric setting identifies more at-risk mothers during the
postpartum period in comparison to screening in an OB/GYN or PCP office. However, screening
for PPD in an OB/GYN or PCP office is useful in reducing barriers associated with receiving
treatment such as the lack of an available therapist, public treatment options, time constraints
and patient reluctance. Thus, screening for PPD within a pediatric setting is beneficial for those
who may not follow up with their OB/GYN or PCP postpartum and may be potentially missed.
Screening in pediatric offices does not have to replace OB/GYN or PCP screenings but rather
enhance encounters for screening PPD in general. If screenings are positive (EPDS total score
 10) in a pediatric setting recommendation for referrals to an OB/GYN or PCP are enforced.
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Education
Patient education is an essential role of the advanced practice registered nurse.
Educating participants about the best practices, signs and symptoms of PPD, purpose of
screening and available community resources was incorporated into the implemented protocol
within this project. Education was the main focus on the PPD information which was provided
for all participants, to ensure they were informed about PPD and its consequences. Participants
expressed an increase of knowledge about PPD and great use of the reliable community
resources. With the information the participants received, they expressed that it allowed them to
be well-informed of their options available for assistance and support. Provider education is
important regarding treatment and management of PPD. For instance, providers can shine
some light on how to manage or provide different coping techniques for PPD. This project
helped providers familiarize themselves with community resources, educate participants, and
support and assisting participants with their individual needs. Implications for further research
can include the impact of mother’s mental health effects on the mother-infant dyad. Research is
needed to further educate providers regarding the benefits of screening women during the
postpartum period at well-child visits in relations to child development.
Conclusion
The You’re Not Forgotten project has enhanced the site facilitator, staff, and project
participants understanding of the value of screening for PPD within a pediatric setting. The site
facilitator expressed satisfaction with the project’s impact on the clinic and a desire to continue
to screen mothers for PPD at this practice. Methods for sustainability are underway at the
project site with possible incorporation into the new EMR system with appropriate staff training.
The project facilitator was receptive to continued used of educational information aids including
the use of the EPDS screening tool to disperse to eligible patients. The project site facilitator
plans to follow the guidelines of the AAP and provide PPD screening to eligible mothers with a
referral protocol for individuals who are at higher risk. During the 12-week post-intervention
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phone call, participants also expressed their satisfaction of being screened for PPD in a
pediatric setting, while many did not follow up with their own OB/GYN or PCP.
In conclusion, results of this project support the effectiveness of screening mothers for
PPD in a pediatric setting and are consistent with the current literature. There was a significant
difference in PPD risk scores from participants who were screened pre-intervention and rescreened post-intervention. While there was no statistical significance on the demographic
characteristics and EPDS scores within this project, larger sample studies have supported that
those who suffer from any mental illness have a higher risk of screening positive for PPD.
Patient education and appropriate referral protocol procedures are an essential
component for best practice protocols which should be in place to ensure patients are receiving
the proper treatment needed. Hence, this project has initiated a patient-centered practice
change that will continue to positively impact the mother-infant dyad. It is recommended that
providers incorporate this screening process within their practices to help individuals who are at
high risk for depression to have access to medical information and treatment.
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Appendix A
Appraisal of Evidence Table

Citation (APA)

Purpose

Association of Women’s
Health, Obstetric and
Neonatal Nurses [AWHONN].
(2015). Mood and anxiety
disorders in pregnant and
postpartum women JOGNN Journal of Obstetric,
Gynecologic, and Neonatal
Nursing, 44(5), 687-689.

Guidelines for
providers to
screen and
treat perinatal
psychiatric
distress in
facilities that
serve pregnant
women, new
mothers, and
newborns.

Design
Clinical
guideline/
Position
statement

Sample
Pregnant and
postpartum women

Measurement/
Outcomes
Recommendation
for measuring
mood and anxiety
disorders within
different settings.

Results/Findings
Recommended to
use a screening
tool to measure
postpartum
depression for
postpartum
mothers to
identify risk of
postpartum
depression.
Facilities caring
for pregnant and
postpartum
women should
have policies in
place to care for
these disorders.

Level/
Quality
Level IV/
Good (B)
quality
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Citation (APA)

Purpose

Emerson, M. R., Mathews, T.
L., & Struwe, L. (2018).
Postpartum depression
screening for new mothers at
well child visits. MCN: The
American Journal of Maternal
Child Nursing, 43(3), 139–
145.

Determine
prevalence of
mothers who
scored in the
at-risk range
using
Edinburgh
Postnatal
Depression
Scale (EPDS)
at each of the
2, 4, and 6
month well
child visits
(WCV).
Examine
feasibility
factors relative
to extending
the current
standard of
care for PPD
screening.
Examine visit
documentation
for at-risk
mothers

Design
Prospective
cohort

Sample
Perinatal
women/postpartum
women attending
their infants’ 6
month well child
visit in a pediatric
outpatient practice.

Measurement/
Outcomes
Measuring PPD
at 2, 4 and 6
month WCVs,
using the EPDS.

Results/Findings
43 women were
included, 10% for
2 month visit,
12.5% for 4
month visit & 14%
for 6 month visit.
Prevalence of
PPD among
participants is
consistent with
previously
reported rates.
Identified
Improvements for
clinical practice
include: (a)
content of visit
that is
documented in
medical record
(b) review
screening results
with mothers at
risk (c) time for
clinical team to
conduct
screening and (d)
appropriate
referral to outside
sources.

Level/
Quality
Level I/
High
(A)quality
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Citation (APA)

Purpose

Friedman, S., Rochelson, E.,
Fallar, R., & Mogilner, L.
(2016). Postpartum
depression in a general
pediatric practice. Clinical
Pediatrics, 55(9), 793–799.

The effects of
an educational
session about
PPD and
modification of
the electronic
medical record
(EMR) on
providers’
screening for
PPD.

Design
Quasiexperimental
study

Sample
Postpartum
women

Measurement/
Outcomes
Educational
session provided
for the physicians
and a pre and
post surveys
completed
comparing
comfort and selfreported
screening. EMR
educational
changes in 3
groups: group 1before the
conference,
group 2-after the
conference but
before EMR
change and
group 3- after
screening in the
EMR.

Results/Findings
Documented
screening
increased form
0% in group 1, to
2% in group 2, to
74% in group 3
(p<.001). 10%
screened positive
but only 14% had
documented
referrals to a
provider for
treatment. The
combination of
provider
education and
screening
questions
integrated into the
EMR enhanced
PPD screening
rates in a
pediatric busy
practice.

Level/
Quality
Level II/
Good (B)
quality
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Citation (APA)

Purpose

Design

Gilbert, A. L., Balio, C., &
Bauer, N. S. (2017). Making
the legal and ethical case for
universal screening for
postpartum mood and anxiety
disorders in pediatric primary
care. Current Problems in
Pediatric & Adolescent Health
Care, 47(10), 267–277.

Provide
information
regarding
universal
screening for
PPD using
validated tools
in pediatric
primary care
settings for
new caregivers
by making the
legal and
ethical case for
this course of
action in a
manner that is
both
compelling and
accessible for
clinicians.

Nonexperimental
study (literature
review)

Sample
Postpartum
women

Measurement/
Outcomes
Assessment of
literature as it
applies to
provider
responsibilities,
liabilities and
perspectives, and
caregiver
autonomy,
confidentially and
privacy. The
assessment of
the balancing
benefits across
multiple
populations.

Results/Findings
There is a strong
ethical and legal
case for universal
screening for
PPD and
postpartum mood
and anxiety
disorders
(PMADs) in a
pediatric primary
care setting using
validated tools
when informed
consent can be
obtained and
appropriate
follow-up services
are available and
accessible.

Level/
Quality
Level V/
Good (B)
quality
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Citation (APA)

Purpose

Gyi, Aye. (2018). Postpartum
depression: Assessment
[Recommended practice].
Retrieved from Joann Briggs
Institute EBP Resources
website
http://joannabriggslibrary.org/.

Details about
the best
available
evidence
regarding
assessment for
postpartum
depression.

Design
Evidence
summary

Sample
Postpartum
women

Measurement/
Outcomes
Recommendation
for the use of
Edinburg
Postnatal
Depression Scale
(EPDS) in all
clinical settings
involved in care
for postpartum
women.

Results/Findings
Recommendation
for all healthcare
professionals
involved in the
care of
postpartum
women to utilize a
screening tool
(EPDS) to
measure
postpartum
depression.
Recommendation
on evaluation of
screening tools
and
recommendation
on referral
process for
positive
screenings.

Level/
Quality
Level V/
High (A)
quality

75

Citation (APA)

Purpose

Design

Kurtz, S., Levine, J., &
Safyer, M. (2017). Ask the
question: Screening for
postpartum mood and anxiety
disorders in pediatric primary
care. Current Problems in
Pediatric & Adolescent Health
Care, 47(10), 241–253

Addressing the
concerns of
implementing
postpartum
screening
within a
pediatric
primary care
setting.

Literature review

Sample
Postpartum
women

Measurement/
Outcomes
Identifying the
type of
postpartum mood
and anxiety
disorders in order
to properly
develop a plan
for screening in a
pediatric setting.
Using a Plan-DoStudy-Act
(PDSA) cycle to
implement
screening for
postpartum
depression in a
pediatric setting.
Using EPDS and
PHQ-2 and PHQ9 to identify risk
of postpartum
depression and
other mood
disorders.

Results/Findings
Using this model,
proper
implementation of
a screening
process in a
pediatric setting is
applicable.

Level/
Quality
Level V/
Good (B)
quality
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Citation (APA)

Purpose

Leis, J. A., Solomon, B. S.,
Wasserman, K. E., Carter, T.
N., Mendelson, T., Perry, D.
F., & Tandon, S. D. (2015).
Preventing postpartum
depression in a pediatric
primary care clinic: A pilot
study. Clinical
Pediatrics, 54(5), 487–490.

Integrate an
evidencebased
preventive
intervention for
perinatal
depression into
a pediatric
primary care
clinic serving
low income,
minority
families, and to
explore
intervention
acceptability
and preliminary
outcomes.

Design
Pilot study

Sample
Postpartum
women who were
identified to have
depressive
symptoms on the
U.S. Preventive
Services Task
Force (USPSTF)
2-item depression
screener during
newborn, 2- and 4month well-baby
visits. An urban,
academic pediatric
primary care clinic
serving
predominately lowincome families.

Measurement/
Outcomes
Two cohorts of
mothers
completed a
Mothers and
Babies (MB)
course ( 6
weekly, 2 hour
sessions which
are divided into 3
modules)

Results/Findings
Total of 15
women
participated; 5 in
which attended 0
or 1 session,
while 10 women
attended 4 or
more sessions/
the mean number
of sessions
attended by
completers was
5.3 indicating
excellent
engagement in
the intervention.
The results from
this study support
pediatric primary
care as an
promising setting
to implement
maternal mental
health
intervention.

Level/
Quality
Level II/
Good (B)
quality

77

Citation (APA)

Purpose

Mgonja, S., & Schoening, A.
(2017). Postpartum
depression screening at wellchild appointments: A quality
improvement project. Journal
of Pediatric Healthcare,
31(2), 178–183.

To implement
and evaluate a
postpartum
depression
program using
Edinburgh
Postnatal
Depression
Scale (EPDS)
during well
child
appointments
up to 1 year in
a pediatric
primary care
setting.

Design
Quality
Improvement
project

Sample
Postpartum
women ages 19
years and older at
their infants’ wellchild appointments
at a faith-based
clinic in the
Midwest.

Measurement/
Outcomes
Using the PlanDo-Study-Act
framework, the
EPDS was
administered to
mothers at well
child
appointments up
to 1 year of age..
Score of 10 or
greater was
considered
positive and
evaluated every 2
weeks.

Results/Findings
Total of 35
(97.3%) mothers
completed the
EPDS tool during
9 week
implantation
periods. Staff
compliance rate
with administering
EPDS was 78.7%
there were 10
missed
opportunities
(21.3%) There
were 5 positive
EPDS results
(14.3%).

Level/
Quality
Level V/
High (A)
quality
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Citation (APA)

Purpose

Olin, S. S., McCord, M.,
Stein, R. E. K., Kerker, B. D.,
Weiss, D., Hoagwood, K. E.,
& Horwitz, S. M. (2017).
Beyond screening: A stepped
care pathway for managing
postpartum depression in
pediatric settings. Journal of
Women’s Health, 26(9), 966–
975.

Provide a
stepped care
approach for
screening and
managing PD,
integrating
common
elements found
in existing
pediatric-based
models.

Design
Literature
Review

Sample
Postpartum
women

Measurement/
Outcomes
Care pathway
begins with
systematic
screening for
depression
symptoms,
followed by a
systematic risk
assessment for
women who
screen positive
and care
management
based on risk
profiles and
responsiveness.
A four step
process included:
screening for
depressive
symptoms,
psychosocial risk
assessment to
triage care, care
management
based on risk
profile & followup and
monitoring PD.

Results/Findings
The importance
of a pediatric
setting is critical
to both maternal
and child wellbeing,
recommendations
follow the USPTF
of screening for
PPD in a pediatric
setting. The
proposed
pathway provides
a testable model
for an important
public health
concern and can
be implemented
within a pediatric
setting to improve
child well-being.

Level/
Quality
Level V/
Good (B)
quality
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Citation (APA)

Purpose

Design

Sample

Measurement/
Outcomes

Puryear, L. J., Nong, Y. H.,
Correa, N. P., Cox, K., &
Greeley, C. S. (2019).
Outcomes of implementing
routine screening and
referrals for perinatal mood
disorders in an integrated
multi-site pediatric and
obstetric setting. Maternal
and Child Health Journal.
10(23), 1292-1298.

Increase
access to
perinatal
mental health
services
through
universal
screening for
postpartum
depression and
facilitating
referrals for
evaluation and
treatment at a
pediatric
practice

Quality
improvement
project

Pregnant and
postpartum women
at a Texas
Children’s Hospital
in Houston, Texas

Pediatric practice
screened women
at 2 weeks, 2,
4,and 6 month
well baby visits,
using the EPDS
screening tool
and recorded in
the electronic
medical record.

Rafferty, J., Mattson, G.,
Earls, M. F., & Yogman, M.
W. (2019). Incorporating
recognition and
management of perinatal
depression into pediatric
practice. Pediatrics, American
Academy of
Pediatrics, 143(1), 1–29.

Guidelines for
improving the
health of all
children.
Guideline for
providers to
utilize to
identify
postpartum
depression in
postpartum
women.

Clinical guideline

Postpartum
women

Postpartum
depression
measurement
within a pediatric
setting and follow
up. Impact PND
have on infant
and family dyad.

Results/Findings
Total of 102,906
screens for PPD
were completed,
6,487 (6.3%)
screened
positive, 3,893
(3.8%) were
referred; of those
referred, 2,172
(55.8%)
completed
appointment with
a mental health
provider.
Concluding that
PPD screening
can be integrated
into a pediatric
setting.
Recommended to
use postpartum
depression
screening tool,
within a pediatric
setting at different
visits (1- 2-, 4-, , 6
months) to
evaluate
postpartum
depression.

Level/
Quality
Level V/
High (A)
quality

Level IV/
High (A)
quality
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Citation (APA)

Purpose

Design

Sorg, M., Coddington, J.,
Ahmed, A., & Richards, E.
(2019). Improving Postpartum
Depression Screening in
Pediatric Primary Care: A
Quality Improvement
Project. Journal of Pediatric
Nursing, 46, 83–88.

To improve
standardized
screening for
postpartum
depression in a
pediatric
primary care
setting

Van der Zee-van den
Berg,A.,BoereBoonekamp,M., IJzerman,
M., HaasnootSmallegange,R., &
Reijneveld, S. (2017).
Screening for postpartum
depression in well-baby care
settings: A systematic review.
Matern Child Health,21, 9-20

Evaluating the
Systematic
evidence of the Review
effectiveness of
screening for
PPD in WBC
settings
regarding
mother and
child outcomes.

Quality
Improvement

Sample
Postpartum
women

Postpartum
women

Measurement/
Outcomes
Implementing a
standardized
postpartum
depression
screening tool
into a pediatric
primary care
practice,
independent
samples t-test
and logistic
regression were
used for data
analysis.
Postpartum
depression
measurement
within a pediatric
setting using
EPDS screening
tool (4 studies).

Results/Findings
Postpartum
depression
screening
practice improved
from 83% to 88%
(p=0.096) [not
high statistically]
Concluded that
pediatric health
care providers
can effectively
screen for
postpartum
depression.
Mothers being
screened in a
pediatric setting
occurred in all
studies with
referral.

Level/
Quality
Level V/
Good
(B)quality

Level II /
High
(A)quality

81

Citation (APA)
Waldrop, J., Ledford, A.,
Perry, L. C., & Beeber, L. S.
(2018). Developing a
postpartum depression
screening and referral
procedure in pediatric primary
care. Journal of Pediatric
Healthcare, 32(3), e67–e73.

Purpose

Design

Appraisal of the Systematic
current
Review
evidence on
implementing
screening for
postpartum
depression in a
pediatric
primary care.

Sample
Postpartum
women

Measurement/
Outcomes
Utilizing a
support algorithm
for screening and
follow-up and
process of
developing an
accompanying
referral/resource
list.

Results/Findings
The evidence
supports the use
of a clinical
decision support
algorithm and the
need for having
local resources
an referrals
available at the
point of care.
Screenings within
the pediatric
setting is feasible
an can be
adapted in a local
setting.

Level/
Quality
Level III/
High (A)
quality
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Appendix B
CITI Program
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Appendix C
JHNEBP Model Permission
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Appendix D
Patient Consent and Authorization Form
Date: ___________

Identification #:________
PATIENT CONSENT AND AUTHORIZATION FORM

Project Title: You’re Not Forgotten: The Effects of Screening Postpartum Depression in a
Pediatric Setting
Project Coordinator: Marrisa Culver, BSN, RN, DNP Student, Valparaiso University College of
Nursing
Purpose: I, _____________________________________________ (please print), understand
that I am being asked to participate in an educational intervention project for postpartum
mothers which will screen for postpartum depression in a pediatric setting.
Procedure: The project coordinator will provide the following: an Edinburgh Postnatal
Depression Screening tool (English or Spanish) during well child visits. The screening tool used
is recommended by the American Academy of Pediatrics and the United States Preventive
Services Task Force.
Risk: There are no known physical risks to participate in this project. There are no invasive
techniques or procedures used. This project is designed to increase knowledge and awareness
of postpartum depression and to identify postpartum depression within a pediatric setting. The
project involves collection of information from participants prior to seeing the physician, based
on the score, educational information may be provided or possibly referral to obstetric (OB)
doctor or primary care provider (PCP).
Benefits: Identifying postpartum depression can decrease its effects on mother and baby. The
knowledge gained from this project could provide valuable information regarding postpartum
depression and its screening in a pediatric setting for health care providers, educators and
health organizations. The program could possibly minimize missed opportunities for screenings.
Payment for participation: I understand that I will not be paid for my participation in this
project. I may receive free educational brochures and community resources.
Additional Cost: I understand there will be no cost for me to participate in this project.
Voluntary Participation/Withdrawal: I understand that my participation in this project is my
choice and I am free to stop at any time without penalty.
Questions: If I have any questions about my participation in the project or in the future, Marrisa
Culver may be contacted at 219-895-8650 or through her email address at
marrrisa.culver@valpo.edu. If you have questions about my rights as a project participant,
Rasha Abed, Associate Director of the Institutional Review Board at Valparaiso University, may
be contacted at (219) 464-5798.
Confidentiality/Anonymity: Although information that I will give on the screening tool
(questionnaire) may be used and reported by the project coordinator, my name and facts that
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would identify me will be kept strictly confidential. I have been assured of my anonymity I the
reporting of data.
Consent to Participant in Project Study: I have read or had read to me all of the above
information about this project, the procedure, possible risk, and potential benefits and I
understand them. All of my questions have been answered. I give consent and permission freely
to participate in this project.

Participants Signature

Date

_________________________________

_________________

Project Coordinator’s Signature

Date

_________________________________

_________________
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Appendix E
Personal Data Form
PERSONAL DATA FORM
Name:
Baby DOB or age?:
Mother Race:
Mother yearly income level (circle one that applies): less than $25,000 $25,000-$49,999
$50,000-$74,999 $75,000+
Highest educational level achieved (circle one that applies): Elementary High School Some
College College Graduate Graduate School
Past medical history of (circle all that apply): depression, post-partum depression, anxiety, mood
disorders, other _____________
Current under treatment for depression or other psychological disorder? Yes or No If Yes,
explain_____________________________________________________
Follow up with OB provider since delivery? Yes or No Identify how many weeks postpartum.

Personal Contact Information:
Ph: _____________________________________________
Email: __________________________________________

Primary Care Provider or Obstetric (OB) Provider Contact Information:
Name: _____________________________________________
Phone: _____________________________________________
Provider seeing today: MD

PA

NP

I, ______________________________________ give permission to the project coordinator
and/or healthcare provider to contact my provider regarding the results of my screening.
If the results of my screening indicate a high risk for depression, I give my permission for the
project coordinator to contact me within 2 weeks of my visit via telephone to follow-up on my
symptoms. YES or NO

Signature: ________________________________________________ Date: ______________
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Appendix F
Edinburgh Postnatal Depression Screening Tool
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Appendix G
Community Resource Listing
Fort Wayne Community Resource Listing
Name

Contact Information

Mental Health America of Northeast

1027 W. Rudisill Blvd. Fort Wayne, IN 46807

Indiana

(260) 422-6441

Cross Connections Inc.

4618 East State Blvd. Suite 300 Fort Wayne,
IN 46815
(260) 373-0213

The Peggy F. Murphy Community Grief

5920 Homestead Rd. Fort Wayne, IN 46814

Center

(260) 435-3261 or toll-free (800) 288-4111

Park Center Walk-in Clinic

2710 Lake Ave. Fort Wayne, IN 46805
(260)471-9440 or (260) 969-8440

Suicide National Hotline

(800) 273-8255

Park Center

(260) 481-2700 or (866) 481-2700

Parkview Behavioral Health

(260) 373-7500 or (800) 284-8439

